* Enters licensing agreements with Leo Pharma in skin
diseases
Read more
Thursday, June 30, 2016
German stocks - Factors to watch on July 1
FRANKFURT, July 1 (Reuters) - The DAX top-30 index
looked set to open 0.4 percent higher on Friday, according to
premarket data from brokerage Lang & Schwarz at 0619 GMT.
The following are some of the factors that may move German
stocks:
Read more
looked set to open 0.4 percent higher on Friday, according to
premarket data from brokerage Lang & Schwarz at 0619 GMT.
The following are some of the factors that may move German
stocks:
Read more
Swiss stocks - Factors to watch on July 1
ZURICH, July 1 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Friday:
Read more
main factors expected to affect Swiss stocks on Friday:
Read more
Spanish stocks - Factors to watch on Friday
The following Spanish stocks may be affected by newspaper
reports and other factors on Friday. Reuters has not verified
the newspaper reports, and cannot vouch for their accuracy:
Read more
reports and other factors on Friday. Reuters has not verified
the newspaper reports, and cannot vouch for their accuracy:
Read more
BRIEF-Guangdong Biolight Meditech to get stakes in medical device firm for 60 mln yuan
* Says it plans to acquire 60 percent stake in a
Changzhou-based medical device firm from two individuals
Read more
Changzhou-based medical device firm from two individuals
Read more
UPDATE 1-China factory activity stalls in June, more stimulus expected
BEIJING, July 1 (Reuters) - Growth in China's manufacturing
sector stalled in June, an official survey showed on Friday,
adding to expectations that Beijing will have to roll out more
stimulus soon to boost the sluggish economy.
Read more
sector stalled in June, an official survey showed on Friday,
adding to expectations that Beijing will have to roll out more
stimulus soon to boost the sluggish economy.
Read more
BRIEF-InspireMD announces pricing of public offering of approximately $14.6 mln
* Each share of series B convertible preferred stock is
convertible into 100 shares of common stock at price equal to
$0.33 per share
Read more
convertible into 100 shares of common stock at price equal to
$0.33 per share
Read more
UPDATE 1-NuVasive settles spinal surgery patent fight with Medtronic
June 30 (Reuters) - Medical device maker NuVasive Inc
will pay rival Medtronic Plc $45 million to
settle a longstanding patent fight related to spinal surgery
technology, NuVasive said on Thursday.
Read more
will pay rival Medtronic Plc $45 million to
settle a longstanding patent fight related to spinal surgery
technology, NuVasive said on Thursday.
Read more
BRIEF-Vitae Pharmaceuticals entered controlled equity offering sales agreement with Cantor Fitzgerald & Co on June 30 - SEC Filing
* On June 30, co entered into controlled equity offering
sales agreement with Cantor Fitzgerald & Co - SEC Filing
Read more
sales agreement with Cantor Fitzgerald & Co - SEC Filing
Read more
BRIEF-Healthstream buys Performance Management Services
* Healthstream acquired PMSI through a merger for
approximately $4.0 million in cash at closing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
approximately $4.0 million in cash at closing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Novocure announces $75 mln drawdown under term loan agreement
* Novocure drew $25 million of total $100 million available
borrowing capacity when term loan agreement closed in January
2015
Read more
borrowing capacity when term loan agreement closed in January
2015
Read more
UPDATE 1-U.S. doctors, hospitals paid billions by drug, device makers -gov't
NEW YORK, June 30 (Reuters) - Doctors and hospitals in the
United States received $7.52 billion in payments and ownership
and investment interests from the makers of drugs and medical
devices in 2015, according to data released by a government
health agency.
Read more
United States received $7.52 billion in payments and ownership
and investment interests from the makers of drugs and medical
devices in 2015, according to data released by a government
health agency.
Read more
Two of three German A400M planes grounded due to engine issues-ministry
BERLIN, June 30 (Reuters) - Germany has grounded two of its
three A400M military transport planes delivered by Airbus Group
SE due to newly discovered gearbox issues on their
turboprop engines, a spokesman for the German defence ministry
said on Thursday.
Read more
three A400M military transport planes delivered by Airbus Group
SE due to newly discovered gearbox issues on their
turboprop engines, a spokesman for the German defence ministry
said on Thursday.
Read more
More U.S. babies with Zika-related birth defects reported by health agency
June 30 (Reuters) - Three more babies have been born in the United States with birth defects likely linked to Zika virus infections, while another lost pregnancy was linked to the virus, according to figures updated by health officials on Thursday.
Read more
Read more
BRIEF-Prim says price of the deal with Laboratorios Milo is not defined
* Says acquisition price of the branches of Laboratorios Milo SA will not be established
until the end of negotiations, with the date scheduled for Sept 1
Read more
until the end of negotiations, with the date scheduled for Sept 1
Read more
RPT-U.N. peacekeeping mission leaves Liberia after 13 years
MONROVIA, June 30 (Reuters) - A U.N. peacekeeping mission
that was sent to Liberia in 2003 to restore order after two
brutal civil wars withdrew on Thursday, beginning a new phase of
self-reliance for the impoverished West African country.
Read more
that was sent to Liberia in 2003 to restore order after two
brutal civil wars withdrew on Thursday, beginning a new phase of
self-reliance for the impoverished West African country.
Read more
UPDATE 1-EU mergers and takeovers (June 30)
BRUSSELS, June 30 (Reuters) - The following are mergers
under review by the European Commission and a brief guide to the
EU merger process:
Read more
under review by the European Commission and a brief guide to the
EU merger process:
Read more
BRIEF-Quantum Genomics initiates phase IIa trial for heart failure
* Opening of the first hospital centres in france and
norway, and the beginning of the phase iia study in heart
failure
Read more
norway, and the beginning of the phase iia study in heart
failure
Read more
BRIEF-Ascendis Health says intends to raise 1.2 billion rand via rights offer
* Intends to raise r1.2 billion, through a fully
underwritten renounceable rights offer to part settle purchase
consideration of acquisitions.
Read more
underwritten renounceable rights offer to part settle purchase
consideration of acquisitions.
Read more
BRIEF-Tesaro files for mixed shelf offering - SEC filing
* Says files for mixed shelf offering with the U.S. SEC;
size undisclosed - SEC filing
Source: (http://1.usa.gov/295fkJh
)
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
size undisclosed - SEC filing
Source: (http://1.usa.gov/295fkJh
)
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
Mylan offers EC concessions to get approval for $7.2 bln Meda buy
BRUSSELS, June 30 - U.S. generic drugmaker Mylan NV
has offered concessions in a bid to allay concerns by EU
competition regulators over its proposed $7.2-billion
acquisition of Swedish rival Meda, the European
Commission said on Thursday.
Read more
has offered concessions in a bid to allay concerns by EU
competition regulators over its proposed $7.2-billion
acquisition of Swedish rival Meda, the European
Commission said on Thursday.
Read more
BRIEF-Galmed Pharmaceuticals says enters research collaboration agreement
* Has right to enter into exclusive negotiations with Yeda
to complete license agreement to commercialize diagnostic,
prognostic tool for Aramchol
Read more
to complete license agreement to commercialize diagnostic,
prognostic tool for Aramchol
Read more
BRIEF-Aratana Therapeutics files for FDA approval of Nocita
* Aratana Therapeutics files for FDA approval of
Nocita(bupivacaine liposome injectable suspension)
Read more
Nocita(bupivacaine liposome injectable suspension)
Read more
BRIEF-Shire reports results for mid-stage trial of shp607 in extremely premature infants
* Shire announces top-line results for phase 2 trial of
shp607 in extremely premature infants
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
shp607 in extremely premature infants
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
COLUMN-Keep Medicare advice SHIP afloat for U.S. seniors
CHICAGO, June 30 (Reuters) - Would you call a U.S. program
that helps 7 million seniors save money on Medicare annually
"unnecessary"?
Read more
that helps 7 million seniors save money on Medicare annually
"unnecessary"?
Read more
BRIEF-Arqule says presents preliminary clinical data for ARQ 087
* Presents preliminary clinical data for arq 087
demonstrating evidence of anticancer activity in intrahepatic
cholangiocarcinoma
Read more
demonstrating evidence of anticancer activity in intrahepatic
cholangiocarcinoma
Read more
Deals of the day- Mergers and acquisitions
June 30 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1000 GMT on
Thursday:
Read more
acquisitions and disposals were reported by 1000 GMT on
Thursday:
Read more
BRIEF-Prim to buy branches of Laboratorios Milo
* Reaches agreement with Laboratorios Milo SA to buy pharmaceutical, orthopedic and
podiatric branches of activity
Read more
podiatric branches of activity
Read more
BRIEF-Medistim's technology has achieved reimbursement in Japan
* Valid from April 1, 2016, Ministry of Health, Labour and Welfare in Japan approved a
reimbursement of YEN 25,000 [EUR 225] when blood flow of the graft is controlled, using either
transit time flow measurement or high-resolution epicardial ultrasonography intraoperatively
Read more
reimbursement of YEN 25,000 [EUR 225] when blood flow of the graft is controlled, using either
transit time flow measurement or high-resolution epicardial ultrasonography intraoperatively
Read more
BRIEF-Pierrel receives payments for a future capital increase from two shareholders
* Said on Wednesday that shareholder Fin Posillipo SpA,
owner of a 36.4 percent stake in Pierrel, made a payment for a
future capital increase of 0.85 million euros ($944,690.00)
Read more
owner of a 36.4 percent stake in Pierrel, made a payment for a
future capital increase of 0.85 million euros ($944,690.00)
Read more
BRIEF-Bioleaders to list shares on KOSDAQ
* Says it will issue 1.2 million shares on Korea Securities
Dealers Automated Quotations Stock Market
Read more
Dealers Automated Quotations Stock Market
Read more
BRIEF-Merck KGaA says Zeiss, Hamilton Thorne to join global fertility alliance
* Says welcomes Zeiss and Hamilton Thorne as new members of
global fertility alliance
Source text for Eikon:
Further company coverage:
Read more
global fertility alliance
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Mithra announces update on European phase III clinical trials for its estetrol-based product candidate Estelle
* Announces that first patient has been screened for
enrolment in European phase III clinical trials for its
estetrol-based product candidateEstelle
Read more
enrolment in European phase III clinical trials for its
estetrol-based product candidateEstelle
Read more
UPDATE 3-Japan regulator approves Canon deal to buy Toshiba unit, warns on method
* Unorthodox deal structure allowed Toshiba to raise cash in
hurry
(Recasts with regulator approval and comments)
Read more
hurry
(Recasts with regulator approval and comments)
Read more
Wednesday, June 29, 2016
BRIEF-Probiodrug and Crossbeta Biosciences enter into strategic partnership
* Probiodrug and Crossbeta Biosciences enter into a
strategic partnership in the field of Alzheimer's disease
biomarkers
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
strategic partnership in the field of Alzheimer's disease
biomarkers
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Kiadis Pharma's ATIR101, has been granted an expansion to its existing orphan drug designation
* Kiadis Pharma's orphan drug designation for ATIR101 further expanded to include treatment
in a hematopoietic stem cell transplantation
Read more
in a hematopoietic stem cell transplantation
Read more
BRIEF-Yongan Pharma's Wuhan unit investigated by Tianjin authorities on a health product
* Says unit Yongan Health Pharmaceutical (Wuhan) Co Ltd
being investigated by Tianjin authorities on a health product
Read more
being investigated by Tianjin authorities on a health product
Read more
BRIEF-Guilin Sanjin Pharmaceutical to fully buy health products firm for 50.6 mln yuan
* Says it will buy 100 percent stake in a Guilin-based
health products company, from the controlling shareholder of the
company, for 50.6 million yuan
Read more
health products company, from the controlling shareholder of the
company, for 50.6 million yuan
Read more
BRIEF-Guilin Sanjin Pharmaceutical to fully buy canned food firm for 8.4 mln yuan
* Says it will buy 100 percent stake in a Guilin-based
canned food company, from the controlling shareholder of the
company, for 8.4 million yuan
Read more
canned food company, from the controlling shareholder of the
company, for 8.4 million yuan
Read more
BRIEF-Syros pharmaceuticals prices IPO of 4 mln shares of its common stock at a public offering price of $12.50 per share
* Pricing of IPO of 4 million shares of its common stock at
a public offering price of $12.50 per share
Read more
a public offering price of $12.50 per share
Read more
FEATURE-Children face "staggeringly high" hunger in conflict-hit Central African Republic
BANGUI, June 30 (Thomson Reuters Foundation) - Clinging to
her toy dog, 18-month-old Clemence Mokbem stares ahead as nurses
rush past to tend to crying babies in the hot, overcrowded
intensive care ward in a Bangui hospital.
Read more
her toy dog, 18-month-old Clemence Mokbem stares ahead as nurses
rush past to tend to crying babies in the hot, overcrowded
intensive care ward in a Bangui hospital.
Read more
PRESS DIGEST- Financial Times - June 30
June 30 (Reuters) - The following are the top stories in the
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
BRIEF-Cesca Therapeutics files for mixed shelf of up to $30 mln
* Files for mixed shelf of up to $30.0 million - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-FDA clears Xpert Carba-R Assay test to detect specific genetic markers
* Clears Xpert Carba-R Assay, test to detect specific
genetic markers for certain antibiotic-resistant bacteria
directly from clinical specimens
Source text: (http://1.usa.gov/296qiLy)
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
genetic markers for certain antibiotic-resistant bacteria
directly from clinical specimens
Source text: (http://1.usa.gov/296qiLy)
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Great Basin Scientific entered into securities purchase agreement to issue $75 mln in senior secured convertible notes
* Entered into securities purchase agreement to issue $75
million in principal face amount of senior secured convertible
notes
Read more
million in principal face amount of senior secured convertible
notes
Read more
Olympics will come and go but Zika is here to stay, scientists say
RIO DE JANEIRO, June 29 (Reuters) - Battered by a presidential impeachment and the worst recession since the Great Depression, Brazil is getting a rare bit of relief as Rio de Janeiro prepares to host the Olympics: declining numbers of Zika infections.
Read more
Read more
BRIEF-VCA Inc announces new $1.68 bln senior credit facility
* Increased its credit facility by approximately $300
million by entering into a new $1.68 billion senior credit
facility
Read more
million by entering into a new $1.68 billion senior credit
facility
Read more
BRIEF-Monsanto seeks up to $7 bln more from Bayer in takeover-Handelsblatt
June 29 (Reuters) - ** The U.S. seed producer has
demanded that Germany's Bayer increase its takeover offer by
$10-15 per share, unnamed sources tell German business daily
Handelsblatt.
Read more
demanded that Germany's Bayer increase its takeover offer by
$10-15 per share, unnamed sources tell German business daily
Handelsblatt.
Read more
Fitch: U.S. Hospitals Experiencing Weaker Volumes of Less Acute Patients
(The following statement was released by the rating agency)
NEW YORK, June 29 (Fitch) A group of the largest Fitch-rated
U.S. for-profit
hospital companies reported an average of 0.2% organic growth in
inpatient
admissions and 2.8% organic growth in admissions adjusted for
outpatient
activity in first quarter 2016 (1Q16). Year-over-year rates of
growth dropped
significantly versus 1Q15, and although seasonal issues played a
role, secular
headwinds to growth are persistent.
These headwinds
Read more
NEW YORK, June 29 (Fitch) A group of the largest Fitch-rated
U.S. for-profit
hospital companies reported an average of 0.2% organic growth in
inpatient
admissions and 2.8% organic growth in admissions adjusted for
outpatient
activity in first quarter 2016 (1Q16). Year-over-year rates of
growth dropped
significantly versus 1Q15, and although seasonal issues played a
role, secular
headwinds to growth are persistent.
These headwinds
Read more
BRIEF-Theraclion announces that a hospital based Italy has signed a commercial agreement for use of Echopulse system
* Announces that A.S.L. 6 Di Livorno, a public hospital
based in Tuscany, Italy, has signed a commercial agreement for
use of Echopulse system
Source text: http://bit.ly/29cOShA
Further company coverage:
(Gdynia Newsroom)
Read more
based in Tuscany, Italy, has signed a commercial agreement for
use of Echopulse system
Source text: http://bit.ly/29cOShA
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Sygnis says investor pledges to buy shares in capital hike
* Sygnis ag receives commitment for the purchase of up to
2.7 million shares within the scope of a capital increase to
finance the acquistion of Expedeon Holdings Ltd.
Source text for Eikon:
Further company coverage:
(Reporting by Frankfurt Newsroom)
Read more
2.7 million shares within the scope of a capital increase to
finance the acquistion of Expedeon Holdings Ltd.
Source text for Eikon:
Further company coverage:
(Reporting by Frankfurt Newsroom)
Read more
BRIEF-UK's CMA says not refer Mckesson unit, AAH Pharma-UDG deal for phase 2 probe
* UK's CMA says decided not to refer merger by Mckesson Corp unit AAH Pharmaceuticals of
MASTA and Sangers to a Phase 2 investigation.
Source text for Eikon: (http://bit.ly/29eSv3J)
(Bengaluru Newsroom)
Read more
MASTA and Sangers to a Phase 2 investigation.
Source text for Eikon: (http://bit.ly/29eSv3J)
(Bengaluru Newsroom)
Read more
UPDATE 1-U.S. lifts "too big to fail" designation of GE's financing unit
June 29 (Reuters) - Lender GE Capital is no longer "too big
to fail" - the U.S. government on Wednesday removed its
"systemically important" designation, a label born of the
financial crisis given to institutions with the potential to
wreck the economy in the event of distress.
Read more
to fail" - the U.S. government on Wednesday removed its
"systemically important" designation, a label born of the
financial crisis given to institutions with the potential to
wreck the economy in the event of distress.
Read more
BRIEF-Kitov Pharmaceuticals announces pricing of $12 mln follow-on public offering
* Kitov pharmaceuticals announces pricing of $12 million
follow-on public offering in the U.S.A.
Read more
follow-on public offering in the U.S.A.
Read more
FDA asks for more data on over-the-counter hand sanitizers
June 29 (Reuters) - The U.S. Food and Drug Administration
said it is requesting additional data to support the safety and
effectiveness of certain active ingredients used in topical
consumer antiseptic rubs, including hand sanitizers, that are
sold over-the-counter.
Read more
said it is requesting additional data to support the safety and
effectiveness of certain active ingredients used in topical
consumer antiseptic rubs, including hand sanitizers, that are
sold over-the-counter.
Read more
U.S. lifts "too big to fail" designation of GE's financing unit
WASHINGTON, June 29 (Reuters) - Lender GE Capital on
Wednesday became the first firm to lose its designation as
"systemically important," a label born of the financial crisis
that the U.S. government gives to institutions with potential to
wreck the economy in the event of distress.
Read more
Wednesday became the first firm to lose its designation as
"systemically important," a label born of the financial crisis
that the U.S. government gives to institutions with potential to
wreck the economy in the event of distress.
Read more
BRIEF-GE Capital cancels status as "systemically important"
* GE Capital receives approval for rescission of status as
systemically important financial institution
Read more
systemically important financial institution
Read more
BRIEF-Serodus completes private placement
* Offered 9.7 million shares raising gross proceed of 10 million Norwegian crowns ($1.19
million)
Source text for Eikon:
Further company coverage:
($1 = 8.4265 Norwegian crowns)
(Gdynia Newsroom)
Read more
million)
Source text for Eikon:
Further company coverage:
($1 = 8.4265 Norwegian crowns)
(Gdynia Newsroom)
Read more
UPDATE 1-Tesaro's ovarian cancer drug shows benefit in late-stage trial
June 29 (Reuters) - Tesaro Inc said its ovarian
cancer drug met the main goal of prolonging survival in
patients, without the disease worsening, in a late-stage trial,
sending its shares up 84 percent in premarket trading.
Read more
cancer drug met the main goal of prolonging survival in
patients, without the disease worsening, in a late-stage trial,
sending its shares up 84 percent in premarket trading.
Read more
BRIEF-NatureWise Biotech & Medicals gets patent in India
* Says it got patent for cinamic compounds and derivatives
therefrom for the inhibition of histone deacetylase in India
Read more
therefrom for the inhibition of histone deacetylase in India
Read more
BRIEF-Zhuhai Hokai Medical Instruments' unit plans buyout fund with partners
* Says unit plans to set up buyout fund with partners worth
1 billion yuan ($150.40 million)
Read more
1 billion yuan ($150.40 million)
Read more
BRIEF-Biosearch's probiotic strain registered in China
* Says its probiotic strain Lactobacillus fermentum CECT5716
LC40 has been registered in China
Read more
LC40 has been registered in China
Read more
BRIEF-NNIT signs new client in life sciences segment
* Signed a five-year, medium-size double-digit million Danish crown agreement with Ambu
on outsourcing company's IT infrastructure to NNIT
Source text for Eikon:
Read more
on outsourcing company's IT infrastructure to NNIT
Source text for Eikon:
Read more
BRIEF-Biotie Therapies appoints new CEO and CFO
* Timo Veromaa, President and CEO, David Cook, CFO and Stephen Bandak, CMO of Biotie are
leaving company by June 30, 2016
Read more
leaving company by June 30, 2016
Read more
Tuesday, June 28, 2016
BRIEF-Techno Medica receives approval to extend submitting of annual report for FY 2016
* Says it has received the approval to extend the deadline
of submitting the annual report for fiscal year ended March 31,
2016 to July 29, instead of June 30
Read more
of submitting the annual report for fiscal year ended March 31,
2016 to July 29, instead of June 30
Read more
BRIEF-Kangmei Pharmaceutical completes private placement of 8.1 bln yuan
* Says it completes the issue of 530,104,709 A shares at
15.28 yuan per share, for 8.1 billion yuan via private placement
Read more
15.28 yuan per share, for 8.1 billion yuan via private placement
Read more
California gets go-ahead to vote on legalization of marijuana
June 28 (Reuters) - Californians are set to decide whether
to make recreational marijuana use legal, as other Western
states have done, after the California Secretary of State's
office said on Tuesday the issue could be put to voters in the
November ballot.
Read more
to make recreational marijuana use legal, as other Western
states have done, after the California Secretary of State's
office said on Tuesday the issue could be put to voters in the
November ballot.
Read more
BRIEF-Solasto starts listing on TES first section and announces change in shareholding structure
* Says the company started listing on the Tokyo Stock
Exchange(TSE) first section, effective June 29
Read more
Exchange(TSE) first section, effective June 29
Read more
UPDATE 2-U.S. panel backs claim Lilly diabetes drug cuts cardiac death
June 28 (Reuters) - Eli Lilly & Co and Boehringer
Ingelheim should be allowed to claim that their diabetes drug
Jardiance cuts the risk of cardiovascular death, an advisory
panel to the U.S. Food and Drug Administration concluded on
Tuesday.
Read more
Ingelheim should be allowed to claim that their diabetes drug
Jardiance cuts the risk of cardiovascular death, an advisory
panel to the U.S. Food and Drug Administration concluded on
Tuesday.
Read more
BRIEF-Hudson Executive Capital dissolves stake in Heartware International as of June 27
* Hudson Executive Capital LP dissolves stake in Heartware
International as of June 27 - SEC filing
Read more
International as of June 27 - SEC filing
Read more
BRIEF-Trividia initiates recall of certain lots of TRUEread, TRUEbalance, TRUEtrack & TRUEtest blood glucose test strips
* Trividia Health Inc initiates voluntary recall of certain
lots of TRUEread, TRUEbalance, TRUEtrack & TRUEtest blood
glucose test strips
Read more
lots of TRUEread, TRUEbalance, TRUEtrack & TRUEtest blood
glucose test strips
Read more
BRIEF-Hemostemix says Criterium notified it has terminated master services agreement
* Criterium notified co it has terminated master services
agreement dated June 7, 2014 relating to clinical research
services
Read more
agreement dated June 7, 2014 relating to clinical research
services
Read more
U.S. FDA panel backs claim Lilly diabetes drug
June 28 (Reuters) - Eli Lilly & Co and Boehringer
Ingelheim should be allowed to claim that their diabetes drug
Jardiance cuts the risk of cardiovascular death, an advisory
panel to the U.S. Food and Drug Administration concluded on
Tuesday.
Read more
Ingelheim should be allowed to claim that their diabetes drug
Jardiance cuts the risk of cardiovascular death, an advisory
panel to the U.S. Food and Drug Administration concluded on
Tuesday.
Read more
BRIEF-Moody's - Medtronic's Heartware deal and dividend increase are credit negative
* Medtronic's Heartware deal and dividend increase are
credit negative
Source text for Eikon:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
credit negative
Source text for Eikon:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-U.S. FDA says continues to find benefits of flumist quadrivalent outweigh any potential risks
* FDA continues to find that the benefits of flumist
quadrivalent outweigh any potential risks
Read more
quadrivalent outweigh any potential risks
Read more
UPDATE 1-Brazil's Hypermarcas sinks as former executive admits bribery
SAO PAULO/BRASILIA, June 28 (Reuters) - Shares in
Hypermarcas SA, the largest Brazilian producer of generic drugs,
had their biggest intraday plunge in four years on Tuesday, on
reports that a former senior executive admitted paying bribes to
ruling coalition politicians.
Read more
Hypermarcas SA, the largest Brazilian producer of generic drugs,
had their biggest intraday plunge in four years on Tuesday, on
reports that a former senior executive admitted paying bribes to
ruling coalition politicians.
Read more
BRIEF-Endo International announces issuance of Vasostrict patent
* Patent no. 9,375,478 has been submitted to FDA's Approved
Drug Products; to have submission date of June 28
Read more
Drug Products; to have submission date of June 28
Read more
UPDATE 2-Divided U.S. top court rejects family pharmacy's religious claim
WASHINGTON, June 28 (Reuters) - A divided U.S. Supreme Court
turned away an appeal by a family-owned pharmacy that cited
Christian beliefs in objecting to providing emergency
contraceptives to women under a Washington state rule, prompting
a searing dissent by conservative Justice Samuel Alito.
Read more
turned away an appeal by a family-owned pharmacy that cited
Christian beliefs in objecting to providing emergency
contraceptives to women under a Washington state rule, prompting
a searing dissent by conservative Justice Samuel Alito.
Read more
Funding to combat Zika fails to advance in U.S. Senate
WASHINGTON, June 28 (Reuters) - Funding to battle the Zika
virus failed to advance in the U.S. Senate on Tuesday, as
Democrats blocked a Republican proposal that they said would
short-change the challenge posed by the mosquito-borne virus as
well as other health priorities.
Read more
virus failed to advance in the U.S. Senate on Tuesday, as
Democrats blocked a Republican proposal that they said would
short-change the challenge posed by the mosquito-borne virus as
well as other health priorities.
Read more
UPDATE 1-Gilead wins U.S. nod for drug for all types of hepatitis C
June 28 (Reuters) - U.S. health regulators on Tuesday
approved a combination drug by Gilead Sciences Inc that
is the first available treatment for all six major forms of
hepatitis C, advancing the company's leadership in the field and
sending its shares up almost 4 percent.
Read more
approved a combination drug by Gilead Sciences Inc that
is the first available treatment for all six major forms of
hepatitis C, advancing the company's leadership in the field and
sending its shares up almost 4 percent.
Read more
BRIEF-Welsh Carson Anderson & Stowe X LP dissolves stake in Universal American
* Welsh Carson Anderson & Stowe X Lp Dissolves Stake In
Universal American Corp As Of June 27 - Sec filing
Read more
Universal American Corp As Of June 27 - Sec filing
Read more
CORRECTED-Zika vaccines prove 100 percent protective in mice; monkey study shows promise
CHICAGO, June 28 (Reuters) - Mice given a single shot of one of two experimental Zika vaccines were completely protected when exposed to the virus one to two months later, a promising sign that similar vaccines under development for humans will protect against Zika, U.S. researchers said on Tuesday.
Read more
Read more
BRIEF-Ab-Biotics to run a capital hike of up to 5 million euros
* To run a capital hike of up to 5 million euros ($5.5
million) issuing 3.1 million new shares at 1.60 euro per share
(0.05 euro nominal value plus share premium)
Read more
million) issuing 3.1 million new shares at 1.60 euro per share
(0.05 euro nominal value plus share premium)
Read more
BRIEF-Monsanto and Nomad Bioscience announce collaboration on gene-editing research
* Monsanto and Nomad Bioscience announce collaboration on
gene-editing research for next-generation agriculture solutions
Read more
gene-editing research for next-generation agriculture solutions
Read more
BRIEF-Pharmstandard recommends to approve mandatory tender offer from Augment Investments
* Says board recommends to approve mandatory tender offer
from Augment Investments
Source text: http://bit.ly/28ZH6To
Read more
from Augment Investments
Source text: http://bit.ly/28ZH6To
Read more
BRIEF-Auris Medical completes enrollment of Phase 3 TACTT3 trial
* Auris Medical completes enrollment of Phase 3 TACTT3 trial
with Keyzilen in acute and post-acute inner ear tinnitus
Read more
with Keyzilen in acute and post-acute inner ear tinnitus
Read more
BRIEF-Celyad says study has not succeeded - conference call
* Says with p-value witnessed optimistic that a partner will
take this further in the U.S. - conf call
Read more
take this further in the U.S. - conf call
Read more
BRIEF-Anthem says not in talks with Cigna Corp to end merger - StreetInsider, citing Bloomberg
* Anthem says not in talks with Cigna Corp to end merger -
StreetInsider, citing Bloomberg
Source text : (http://bit.ly/2914pNH)
(Bengaluru Newsroom: +1 646 223 8780)
Read more
StreetInsider, citing Bloomberg
Source text : (http://bit.ly/2914pNH)
(Bengaluru Newsroom: +1 646 223 8780)
Read more
Deals of the day- Mergers and acquisitions
June 28 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1000 GMT on Tuesday:
Read more
acquisitions and disposals were reported by 1000 GMT on Tuesday:
Read more
BRIEF-Vivoline Medical elects Magnus Nilsson Chairman
June 28 (Reuters) - Vivoline Medical AB :
* Elects Magnus Nilsson Chairman
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-UK's CMA says not to recommend McKesson-Bupa Home deal to in-depth investigation
* Decided not to recommend McKesson Corp deal with Bupa Home
Healthcare to a phase 2 investigation
Source text: http://bit.ly/292ycrB
Further company coverage:
(Bengaluru Newsroom)
Read more
Healthcare to a phase 2 investigation
Source text: http://bit.ly/292ycrB
Further company coverage:
(Bengaluru Newsroom)
Read more
BRIEF-Winning Health Technology sees H1 profit up sharply on business expansion
* Says it expects H1 profit to rise about 619-644 percent
y/y to 420.5-435.1 million yuan ($63.24-$65.44 million)
Read more
y/y to 420.5-435.1 million yuan ($63.24-$65.44 million)
Read more
BRIEF-Ando Health to provide 650 mln yuan loan guarantee for units
* Says the co will provide loan guarantee of 650 million
yuan in total for wholly owned units Andon Holdings Co., Ltd
(BVI) and iHealth Labs Europe
Read more
yuan in total for wholly owned units Andon Holdings Co., Ltd
(BVI) and iHealth Labs Europe
Read more
BRIEF-Nipro to repurchase 5 mln shares for 5 bln yen
* Says it will repurchase up to 5 million shares of its
common stock, representing a 2.9 percent stake from June 29 to
Dec. 28
Read more
common stock, representing a 2.9 percent stake from June 29 to
Dec. 28
Read more
Monday, June 27, 2016
BRIEF-DBV Technologies completes recruitment global phase III study of viaskin peanut
* Announces on Monday the completion of recruitment in
global phase III study of viaskin peanut for the treatment of
peanut allergic children
Read more
global phase III study of viaskin peanut for the treatment of
peanut allergic children
Read more
BRIEF-UMN Pharma signs basic agreement with Protein Sciences
* Says it signed basic agreement with Protein Sciences
Corporation regarding vaccine development for zika virus
infection
Read more
Corporation regarding vaccine development for zika virus
infection
Read more
BRIEF-Xencor enteres into collaboration and license agreement with Novartis
* Xencor announces strategic collaboration for bispecific
programs, including XMAB 14045 and XMAB 13676
Read more
programs, including XMAB 14045 and XMAB 13676
Read more
BRIEF-Wilex granted a patent in Europe for the chemical synthesis of dihydroxyisoleucine
* European patent office grants patent for chemical
synthetic building block dihydroxyisoleucine for production of
Amanitin
Read more
synthetic building block dihydroxyisoleucine for production of
Amanitin
Read more
BRIEF-Yung Zip Chemical Ind says Lee Fang Yu resigns from chairman
June 28 (Reuters) - Yung Zip Chemical Ind :
* Says Lee Fang Yu resigned from chairman of the board
Source text in Chinese: http://985.so/4aRc
Further company coverage:
(Beijing Headline News)
Read more
BRIEF-Andon Health plans to acquire eDevice via share private placement
* Says it plans to raise up to 710 million yuan ($106.80
million) in private placement of shares to fund acquisition of
eDevice
Read more
million) in private placement of shares to fund acquisition of
eDevice
Read more
Court decision shifts abortion battle to state bans
June 27 (Reuters) - The battle over abortion was expected to
shift to measures focusing on the fetus in the wake of the U.S.
Supreme Court's decision striking down a Texas law enacted in
the name of maternal health.
Read more
shift to measures focusing on the fetus in the wake of the U.S.
Supreme Court's decision striking down a Texas law enacted in
the name of maternal health.
Read more
UPDATE 1-Mayne Pharma nears deal for Teva assets -source
June 27 (Reuters) - Australia's Mayne Pharma Group Ltd
on Tuesday said it will acquire U.S. generic products
from Teva Pharmaceuticals for $652 million, helping it
propel into the top 2 in the general oral contraceptives market
in the United States.
Read more
on Tuesday said it will acquire U.S. generic products
from Teva Pharmaceuticals for $652 million, helping it
propel into the top 2 in the general oral contraceptives market
in the United States.
Read more
FEATURE-Japan revamps child welfare, but tens of thousands still institutionalised
TOKYO, June 28 (Reuters) - A baby lies in a metal-bar cot
drinking from a bottle perched on his pillow in a Tokyo
orphanage. There's no one to hold and feed him or offer words of
comfort.
Read more
drinking from a bottle perched on his pillow in a Tokyo
orphanage. There's no one to hold and feed him or offer words of
comfort.
Read more
UPDATE 1-GE Capital to sell bulk of U.S. restaurant franchise loan portfolio
June 27 (Reuters) - General Electric Co said it would
sell a bulk of GE Capital's U.S. restaurant franchise loan
portfolio to three regional banks in separate deals as the
industrial conglomerate winds down its financing arm to reduce
regulatory burden.
Read more
sell a bulk of GE Capital's U.S. restaurant franchise loan
portfolio to three regional banks in separate deals as the
industrial conglomerate winds down its financing arm to reduce
regulatory burden.
Read more
CORRECTED-Researchers may have found second 'superbug' gene in U.S. patient
CHICAGO, June 27 (Reuters) - Scientists may have identified
a second patient in the United States infected with bacteria
carrying the mcr-1 "superbug" gene, which makes bacteria highly
resistant to a last-resort class of antibiotics.
Read more
a second patient in the United States infected with bacteria
carrying the mcr-1 "superbug" gene, which makes bacteria highly
resistant to a last-resort class of antibiotics.
Read more
BRIEF -MediBic cancels business alliance with FOUR SIS & CO
* Says it cancels business alliance with Tokyo-based wedding
dress maker FOUR SIS & CO, which was formed on May 28, 2015
Read more
dress maker FOUR SIS & CO, which was formed on May 28, 2015
Read more
Sunday, June 26, 2016
French and Benelux stocks-Factors to watch on June 27
PARIS, June 27 (Reuters) - Below are company-related news
and stories from French and Benelux media which could have an
impact on the region's markets or individual stocks.
Read more
and stories from French and Benelux media which could have an
impact on the region's markets or individual stocks.
Read more
BRIEF-Nicox added to Russell Global Index
* Nicox added to Russell Global Index
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Zhejiang Hisoar Pharmaceutical to buy stake in Hunan-based co for 105 mln yuan
* Says it to buy 25 percent stake in a Hunan-based new
material co from two individuals and a Hengyang-based limited
partnership
Read more
material co from two individuals and a Hengyang-based limited
partnership
Read more
BRIEF-Tego Science to issue convertible bonds worth 1 bln won
* Says it will issue the second unregistered/unsecured
private convertible bonds, raising 1 billion won in proceeds
Read more
private convertible bonds, raising 1 billion won in proceeds
Read more
UPDATE 1-Fresenius promotes CFO Sturm to CEO job after Schneider quits
BERLIN, June 26 (Reuters) - German healthcare group
Fresenius SE has appointed finance chief Stephan Sturm
as its new chief executive to replace long-serving boss Ulf Mark
Schneider, who quadrupled sales during his 13 years in charge.
Read more
Fresenius SE has appointed finance chief Stephan Sturm
as its new chief executive to replace long-serving boss Ulf Mark
Schneider, who quadrupled sales during his 13 years in charge.
Read more
BRIEF-Medicinova added to Russell 3000 Index and Russell Global Index
* Company has been added to Russell 3000 Index and Russell
Global Index as a result of annual Russell Index reconstitution
Read more
Global Index as a result of annual Russell Index reconstitution
Read more
Fresenius promotes CFO Sturm to CEO job after Schneider quits
BERLIN, June 26 (Reuters) - German healthcare group
Fresenius SE has appointed finance chief Stephan Sturm
as its new chief executive, saying on Sunday that long-serving
boss Ulf Mark Schneider is leaving to pursue other
opportunities.
Read more
Fresenius SE has appointed finance chief Stephan Sturm
as its new chief executive, saying on Sunday that long-serving
boss Ulf Mark Schneider is leaving to pursue other
opportunities.
Read more
TIMELINE-Milestones in legal fight over Texas abortion law
June 26 (Reuters) - The U.S. Supreme Court is set to rule on
Monday on a legal challenge by abortion providers to a Texas law
requiring doctors performing the procedure to have "admitting
privileges" at local hospitals and clinics to meet
hospital-grade standards.
Read more
Monday on a legal challenge by abortion providers to a Texas law
requiring doctors performing the procedure to have "admitting
privileges" at local hospitals and clinics to meet
hospital-grade standards.
Read more
U.S. Supreme Court poised to issue major abortion ruling
WASHINGTON, June 26 (Reuters) - The U.S. Supreme Court is
due on Monday to issue its first major abortion ruling since
2007 against a backdrop of unremitting divisions among Americans
on the issue and a decades-long decline in the rate at which
women terminate pregnancies.
Read more
due on Monday to issue its first major abortion ruling since
2007 against a backdrop of unremitting divisions among Americans
on the issue and a decades-long decline in the rate at which
women terminate pregnancies.
Read more
UPDATE 1-China tightens controls on paid-for internet search ads
BEIJING, June 25 (Reuters) - China's internet regulator said
on Saturday that search engines should tighten management of
paid-for ads in search results, making clear which results are
paid-for and limiting their numbers.
Read more
on Saturday that search engines should tighten management of
paid-for ads in search results, making clear which results are
paid-for and limiting their numbers.
Read more
Friday, June 24, 2016
China tightens controls on paid-for internet search ads
BEIJING, June 25 (Reuters) - China's internet regulator said
on Saturday that search engines should tighten management of
paid-for ads in search results, making clear which results are
paid-for and limiting their numbers.
Read more
on Saturday that search engines should tighten management of
paid-for ads in search results, making clear which results are
paid-for and limiting their numbers.
Read more
Arizona says it has run out of drugs for executions
June 24 (Reuters) - Arizona has run out of execution drugs,
including a sedative implicated in botched lethal injections,
according to a filing on Friday in a court case challenging the
U.S. state's execution methods.
Read more
including a sedative implicated in botched lethal injections,
according to a filing on Friday in a court case challenging the
U.S. state's execution methods.
Read more
Olympics-Golfer Grace pulls out of Olympics due to Zika
June 24 (Reuters) - South African Branden Grace joined a growing list of leading golfers withdrawing from the Rio Olympics on Friday due to concerns about the Zika virus.
Read more
Read more
BRIEF-Frejoy Investment Management reports 9.2 pct passive stake in Sorrento Therapeutics
* Frejoy Investment Management Co Ltd reports 9.2 percent
passive stake in Sorrento Therapeutics Inc as of june 7, 2016 -
SEC filing
Source text: http://1.usa.gov/28TiETY
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
passive stake in Sorrento Therapeutics Inc as of june 7, 2016 -
SEC filing
Source text: http://1.usa.gov/28TiETY
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-Aetna, Humana delivered written notice to each other to extend "end date" with respect to merger from June 30-Dec 31
* Co, Humana delivered written notice to each other to
extend "end date" with respect to merger from June 30, 2016 to
Dec 31, 2016 - sec filing
Source text: http://1.usa.gov/28SE5YM
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
extend "end date" with respect to merger from June 30, 2016 to
Dec 31, 2016 - sec filing
Source text: http://1.usa.gov/28SE5YM
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-Achaogen received second draw of $10 mln on June 20
* On June 20, received second draw in amount of $10.0
million contemplated by terms of a loan and security agreement
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
million contemplated by terms of a loan and security agreement
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
UPDATE 1-Rio doping lab's credentials suspended ahead of Olympics
SAO PAULO, June 24 (Reuters) - The World Anti-Doping Agency
(WADA) has suspended the credentials of a testing laboratory in
Rio de Janeiro that didn't conform with international standards,
just over a month before the city hosts the Olympic Games.
Read more
(WADA) has suspended the credentials of a testing laboratory in
Rio de Janeiro that didn't conform with international standards,
just over a month before the city hosts the Olympic Games.
Read more
UPDATE 1-UK 'Leave' vote deflates hopes for U.S.-EU trade deal
WASHINGTON, June 24 (Reuters) - Britain's looming exit from
the European Union is another huge setback for negotiations on a
massive U.S.-EU free trade deal that were already stalled by
deeply entrenched differences and growing anti-trade sentiment
on both sides of the Atlantic.
Read more
the European Union is another huge setback for negotiations on a
massive U.S.-EU free trade deal that were already stalled by
deeply entrenched differences and growing anti-trade sentiment
on both sides of the Atlantic.
Read more
Glass Lewis urges Medivation shareholders to support current board
June 24 (Reuters) - Medivation Inc said shareholder
advisory firm Glass Lewis & Co has recommended the cancer drug
maker's stockholders to not support Sanofi SA's
efforts to replace the company's board members.
Read more
advisory firm Glass Lewis & Co has recommended the cancer drug
maker's stockholders to not support Sanofi SA's
efforts to replace the company's board members.
Read more
UK "Leave" a final nail in the coffin for stalled U.S.-EU trade deal
WASHINGTON, June 24 (Reuters) - Britain's looming exit from
the European Union is another huge setback for negotiations on a
massive U.S.-EU free trade deal that were already stalled by
deeply entrenched differences and growing anti-trade sentiment
on both continents.
Read more
the European Union is another huge setback for negotiations on a
massive U.S.-EU free trade deal that were already stalled by
deeply entrenched differences and growing anti-trade sentiment
on both continents.
Read more
BRIEF-Pfizer completes acquisition of Anacor
* Continues to expect transaction to be slightly dilutive to
adjusted diluted earnings per share in 2017
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
adjusted diluted earnings per share in 2017
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
BRIEF-Immuron announces e-commerce agreement with QBID in China
* Travelan and protectyn will be covered by
marketing/distribution agreement, with products to be made
available from 1 june
Read more
marketing/distribution agreement, with products to be made
available from 1 june
Read more
BRIEF-Great Basin Scientific receives positive Nasdaq listing determination
* Great Basin receives positive Nasdaq listing determination
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
UPDATE 1-U.S. FDA panel to vote whether diabetes drug cuts cardiac death
June 24 (Reuters) - An advisory panel to the U.S. Food and
Drug Administration will be asked to vote next week on whether a
diabetes drug made by Eli Lilly & Co and Boehringer
Ingelheim cuts the risk of cardiovascular death, according to
documents posted on the agency's website on Friday.
Read more
Drug Administration will be asked to vote next week on whether a
diabetes drug made by Eli Lilly & Co and Boehringer
Ingelheim cuts the risk of cardiovascular death, according to
documents posted on the agency's website on Friday.
Read more
UPDATE 2-FACTBOX-Business reaction to Britain's decision to leave the EU
LONDON, June 24 (Reuters) - Britain's vote to leave the
European Union means uncertainty for markets and companies as
London initiates at least two years of negotiations with the EU.
Read more
European Union means uncertainty for markets and companies as
London initiates at least two years of negotiations with the EU.
Read more
REFILE-To IPO or not to IPO: 2016 to remain tepid as investors stay away (June 22)
June 22 (Reuters) - Last fall, Jessica Mah, the founder and
chief executive of San Francisco-based inDinero, was deluged
with calls from investors wanting to know when the accounting
software maker would go public.
Read more
chief executive of San Francisco-based inDinero, was deluged
with calls from investors wanting to know when the accounting
software maker would go public.
Read more
BRIEF-Sichuan Kelun Pharmaceutical issues 500 mln yuan 2016 second tranche short-term financing notes
* Says it issues 500 million yuan 2016 second tranche
short-term financing notes, with coupon rate of 3.4 percent and
maturity date of March 17, 2017
Read more
short-term financing notes, with coupon rate of 3.4 percent and
maturity date of March 17, 2017
Read more
BRIEF-Sosei Group says appoints Peter Bains as CEO
* Shinichi tamura, sosei founder and group chairman,
president, ceo, appointed as representative executive officer
and executive chairman
Read more
president, ceo, appointed as representative executive officer
and executive chairman
Read more
BRIEF-Glaxosmithkline says though the eu referendum result creates uncertainty and potentially complexity ... It does not currently anticipate a material adverse impact on the business, group's results or financial position
* Glaxosmithkline says though the eu referendum result
creates uncertainty and potentially complexity ... It does not
currently anticipate a material adverse impact on the business,
group's results or financial position
Source text for Eikon:
Further company coverage:
Read more
creates uncertainty and potentially complexity ... It does not
currently anticipate a material adverse impact on the business,
group's results or financial position
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Novartis, Roche say too early to predict impact of Brexit vote
* Roche Holding Ag says key priority is to ensure
that UK environment continues to support scientific innovation
and speedy access of innovative medicines for patients
Read more
that UK environment continues to support scientific innovation
and speedy access of innovative medicines for patients
Read more
BRIEF-Medy-Tox to acquire properties for 82 bln won
* Says it will acquire land and building located in Seoul,
from MIRAE ASSET Life Insurance CO., Ltd.
Read more
from MIRAE ASSET Life Insurance CO., Ltd.
Read more
BRIEF-Mithra Pharmaceuticals signs LOI for estetrol with Fuji Pharmaceuticals
* Signs a Letter of Intent with Fuji Pharmaceuticals to work
towards a broad partnership on Estetrol in women's health, in
multiple indications to be determined in common agreement
Read more
towards a broad partnership on Estetrol in women's health, in
multiple indications to be determined in common agreement
Read more
German pharma lobby says EU drug regulator must leave London
FRANKFURT, June 24 (Reuters) - The association of Germany's
pharmaceuticals industry said the European Union's London-based
drugs regulator, the European Medicines Agency, will have to
relocate after Britain's vote to leave the EU, posing a
considerable administrative burden for drugmakers.
Read more
pharmaceuticals industry said the European Union's London-based
drugs regulator, the European Medicines Agency, will have to
relocate after Britain's vote to leave the EU, posing a
considerable administrative burden for drugmakers.
Read more
Thursday, June 23, 2016
Swiss stocks - Factors to watch on June 24
ZURICH, June 24 (Reuters) - The Swiss blue-chip SMI
was seen opening 7.9 percent lower at 7,388 points on Friday,
according to premarket indications from bank Julius Baer
.
Read more
was seen opening 7.9 percent lower at 7,388 points on Friday,
according to premarket indications from bank Julius Baer
.
Read more
BRIEF-Zhejiang Jianfeng Group to pay 2015 div on June 30
* Says it will pay cash dividend of 1.8 yuan per 10 shares
(before tax) to shareholders for 2015 as a record of June 29
Read more
(before tax) to shareholders for 2015 as a record of June 29
Read more
BRIEF-Andon Health raises 924.2 mln yuan via private placement
* Says it issues 60.8 million shares and raises about 924.2
million yuan via private placement
Read more
million yuan via private placement
Read more
Singapore May factory output +0.9 pct y/y; -0.4 pct m/m
SINGAPORE, June 24 (Reuters) - Singapore's industrial
production in May grew from a year earlier, helped by increases
in pharmaceuticals and electronics output, data showed on
Friday.
Read more
production in May grew from a year earlier, helped by increases
in pharmaceuticals and electronics output, data showed on
Friday.
Read more
BRIEF-Hybio Pharmaceutical receives patent license
* Says it receives a patent license (No. ZL 2014 1
0196509.8), for the manufacturing method of a nesiritide
medicine
Read more
0196509.8), for the manufacturing method of a nesiritide
medicine
Read more
BRIEF-Guangzhou Wondfo Biotech gets CE authentications
* Says it gets two CE authentications for its products,
Finecare FIA Meter Plus and Handheld Colloidal Gold Test
Analyzer
Read more
Finecare FIA Meter Plus and Handheld Colloidal Gold Test
Analyzer
Read more
REFILE-UPDATE 1-Dodd, Frank blast ruling that MetLife not too big to fail
June 23 (Reuters) - A federal court's striking down of the
government's designation of insurer MetLife Inc as
"too-big-to-fail" could undermine efforts to head off another
financial crisis, authors of the landmark Dodd-Frank Wall Street
reform law said.
Read more
government's designation of insurer MetLife Inc as
"too-big-to-fail" could undermine efforts to head off another
financial crisis, authors of the landmark Dodd-Frank Wall Street
reform law said.
Read more
BRIEF-Janssen Inc says Health Canada has approved Simponi for treatment of adults with severe active non-radiographic Axial Spondyloarthritis
* Health canada has approved Simponi for treatment of adults
with severe active non-radiographic Axial Spondyloarthritis
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
with severe active non-radiographic Axial Spondyloarthritis
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
WRAPUP-White House threatens to veto Republicans' Zika funding plan
WASHINGTON, June 23 (Reuters) - The White House on Thursday
threatened to veto the $1.1 billion approved by the U.S. House
of Representatives to fight the Zika virus, blasting the measure
for short-changing the administration's $1.9 billion funding
request.
Read more
threatened to veto the $1.1 billion approved by the U.S. House
of Representatives to fight the Zika virus, blasting the measure
for short-changing the administration's $1.9 billion funding
request.
Read more
Arkansas Supreme Court upholds lethal injection protocols
LITTLE ROCK, Ark., June 23 (Reuters) - The Arkansas Supreme
Court on Thursday upheld execution protocols regarding lethal
injection drugs, moving the state that has not held an execution
in more than a decade closer to resuming capital punishment.
Read more
Court on Thursday upheld execution protocols regarding lethal
injection drugs, moving the state that has not held an execution
in more than a decade closer to resuming capital punishment.
Read more
BRIEF-Cyclacel Pharmaceuticals may issue, sell shares having aggregate offering price of up to $4 mln through FBR
* Sales agreement with FBR Capital Markets & Co; may issue,
sell shares having aggregate offering price of up to $4 million
through FBR
Source text: http://1.usa.gov/28Qcw2y
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
sell shares having aggregate offering price of up to $4 million
through FBR
Source text: http://1.usa.gov/28Qcw2y
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
UPDATE 2- U.S. spurns AstraZeneca's nasal spray flu vaccine as ineffective
LONDON/CHICAGO, June 23 (Reuters) - U.S. health officials
have advised doctors not to use AstraZeneca's FluMist in
the upcoming flu season based on three years of U.S. data
showing that the nasal spray vaccine is not effective at
preventing influenza.
Read more
have advised doctors not to use AstraZeneca's FluMist in
the upcoming flu season based on three years of U.S. data
showing that the nasal spray vaccine is not effective at
preventing influenza.
Read more
UPDATE 1-California insurance commissioner urges DOJ to block Aetna-Humana deal
NEW YORK, June 23 (Reuters) - California Insurance
Commissioner Dave Jones on Thursday urged national antitrust
regulators to block health insurer Aetna Inc's proposed
$34 billion acquisition of Humana Inc.
Read more
Commissioner Dave Jones on Thursday urged national antitrust
regulators to block health insurer Aetna Inc's proposed
$34 billion acquisition of Humana Inc.
Read more
Third of hospitals in developing world lack clean running water - study
LONDON, June 23 (Thomson Reuters Foundation) - At least a
third of hospitals in developing nations do not have clean
running water, a study has found, leading to unsanitary
conditions and further spread of disease in drought-hit areas.
Read more
third of hospitals in developing nations do not have clean
running water, a study has found, leading to unsanitary
conditions and further spread of disease in drought-hit areas.
Read more
BRIEF-Medtech announces 6 new ROSA sales
* Announces Six new ROSA robots sales: 2 in the U.S., 2 in
China, 1 in England and 1 in France
Read more
China, 1 in England and 1 in France
Read more
BRIEF-Carmat begins CE Certification process for its artificial heart
* Carmat has begun, with Dekra, the ce certification process
for its bioprosthetic artificial heart
Read more
for its bioprosthetic artificial heart
Read more
BRIEF-Boston Biomedical announces first orphan drug designation for Napabucasin in gastric/gej cancer
* Boston Biomedical announces first orphan drug designation
for Napabucasin in gastric/gej cancer
Read more
for Napabucasin in gastric/gej cancer
Read more
BRIEF-Supersonic Imagine announces completion patient enrollment in liver fibrosis clinical study
* Supersonic imagine announces the completion of patient
enrollment for pivotal liver fibrosis clinical study in China
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
enrollment for pivotal liver fibrosis clinical study in China
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Visiomed Group signs distribution deal in the US for BewellConnect
* Signs major distribution agreement in the U.S. for
BewellConnect
Source text: http://bit.ly/28UNIFF
Further company coverage:
(Gdynia Newsroom)
Read more
BewellConnect
Source text: http://bit.ly/28UNIFF
Further company coverage:
(Gdynia Newsroom)
Read more
German chemical industry union agrees 5.3 percent pay rise
FRANKFURT, June 23 (Reuters) - Germany's chemical industry
trade union IG-BCE and employers agreed a wage increase of 5.3
percent on Thursday, to be carried out over two steps.
Read more
trade union IG-BCE and employers agreed a wage increase of 5.3
percent on Thursday, to be carried out over two steps.
Read more
GAVI alliance offers matched funds for GSK malaria vaccine pilot
LONDON, June 23 (Reuters) - The GAVI global vaccine alliance
has offered funding of up to $27.5 million for pilot tests of
GlaxoSmithKline's first-generation malaria vaccine, but
only if other organisations promise to match that commitment.
Read more
has offered funding of up to $27.5 million for pilot tests of
GlaxoSmithKline's first-generation malaria vaccine, but
only if other organisations promise to match that commitment.
Read more
BRIEF-Wellcare Health expands Medicaid benefits in Georgia
* Wellcare expands Medicaid benefits in Georgia to promote
preventive care
Source text for Eikon:
Further company coverage:
Read more
preventive care
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Atara Bio receives ATMP classification for its EBV-CTLs product candidate from EMA
* Atara Bio receives advanced therapy medicinal product
classification for allogeneic epstein-barr virus specific
cytotoxic T-Lymphocytes (EBV-CTLs) from European Medicines
Agency (EMA)
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
classification for allogeneic epstein-barr virus specific
cytotoxic T-Lymphocytes (EBV-CTLs) from European Medicines
Agency (EMA)
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-Teva settles patent litigation with AstraZeneca
* Teva settles patent litigation with AstraZeneca allowing
Teva to commercialize its generic version of Byetta (Exenatide
injection) in the United States
Read more
Teva to commercialize its generic version of Byetta (Exenatide
injection) in the United States
Read more
BRIEF-Apellis announces results from Phase 1 complement C3 inhibitor trials
* Apellis Announces Positive Results From Phase 1 clinical
Trials Of Apl 2, a C3 complement inhibitor
Read more
Trials Of Apl 2, a C3 complement inhibitor
Read more
BRIEF-Immunovaccine awarded subcontract to evaluate depovax for development of malaria vaccine targets
* Awarded a subcontract by leidos to evaluate
immunovaccine's depovax(tm) platform for development of peptide
based malaria vaccine targets
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
immunovaccine's depovax(tm) platform for development of peptide
based malaria vaccine targets
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Retrophin announces new data from physician-initiated treatment with RE-024
* Retrophin announces new data from physician-initiated
treatment with RE-024 at the 20th international congress of
Parkinson's disease and movement disorders
Read more
treatment with RE-024 at the 20th international congress of
Parkinson's disease and movement disorders
Read more
Germany embraces glitzy offices to shake up corporate culture
MUNICH/HERZOGENAURACH, Germany, June 23 (Reuters) - Major
German companies are investing in ambitious new buildings
designed to attract top staff and encourage innovation, seeking
to create a more dynamic corporate culture and keep pace with
U.S. rivals despite investor concerns about the cost.
Read more
German companies are investing in ambitious new buildings
designed to attract top staff and encourage innovation, seeking
to create a more dynamic corporate culture and keep pace with
U.S. rivals despite investor concerns about the cost.
Read more
UPDATE 1-AstraZeneca takes $80 mln hit as U.S. spurns nasal flu vaccine
LONDON, June 23 (Reuters) - AstraZeneca said it
would take an $80 million writedown on stocks of its flu vaccine
Flumist Quadrivalent, which is sprayed into the nose, after U.S.
health authorities decided they would not use the product.
Read more
would take an $80 million writedown on stocks of its flu vaccine
Flumist Quadrivalent, which is sprayed into the nose, after U.S.
health authorities decided they would not use the product.
Read more
BRIEF-SciBase insources production of electrodes from Ginolis
* Says production of disposable electrodes for SciBase's device Nevisense will be brought
in-house
Read more
in-house
Read more
BRIEF-Shionogi & Co Ltd adjusts conversion price of 2019 due Euro Yen - denominated convertible bonds with warrants to 4,167.5 yen
* Says it adjusts conversion price of 2019 due Euro Yen -
denominated convertible bonds with warrants to 4,167.5 yen from
4,177.6 yen, effective from April 1
Read more
denominated convertible bonds with warrants to 4,167.5 yen from
4,177.6 yen, effective from April 1
Read more
Wednesday, June 22, 2016
BRIEF-Agfa HealthCare collaborates with IBM and Watson
* Reported on Wednesday that Agfa HealthCare collaborates
with IBM and Watson to advance Cognitive Imaging
Read more
with IBM and Watson to advance Cognitive Imaging
Read more
UPDATE 1-U.S. Republican lawmakers to push $1.1 bln in new Zika funds
WASHINGTON, June 22 (Reuters) - Republicans in the U.S.
House of Representatives and Senate agreed on Wednesday to $1.1
billion to fight the Zika virus, a House Republican lawmaker
said, shortchanging President Barack Obama's funding request and
angering Democrats by making other cuts to pay for it.
Read more
House of Representatives and Senate agreed on Wednesday to $1.1
billion to fight the Zika virus, a House Republican lawmaker
said, shortchanging President Barack Obama's funding request and
angering Democrats by making other cuts to pay for it.
Read more
U.S. Senate Democratic leader dismisses Republicans' Zika funding proposal
WASHINGTON, June 22 (Reuters) - U.S. Senate Democratic
leader Harry Reid said an agreement announced on Wednesday by
House of Representatives Republicans on $1.1 billion in new
funding to fight the Zika virus was not a serious response to
the threat.
Read more
leader Harry Reid said an agreement announced on Wednesday by
House of Representatives Republicans on $1.1 billion in new
funding to fight the Zika virus was not a serious response to
the threat.
Read more
BRIEF-Chongqing Taiji Industry Group units to invest 35 mln yuan to set up drug firm
* Says its three units will invest a combined of 35 million
yuan to set up a drug firm in Hainan
Read more
yuan to set up a drug firm in Hainan
Read more
U.S. congressional Republicans agree on $1.1 bln in new Zika funds
WASHINGTON, June 22 (Reuters) - Republicans in the U.S.
House of Representatives and Senate agreed on Wednesday to $1.1
billion in new funding to fight the Zika virus, a key House
Republican lawmaker said.
Read more
House of Representatives and Senate agreed on Wednesday to $1.1
billion in new funding to fight the Zika virus, a key House
Republican lawmaker said.
Read more
BRIEF-Aurinia announces closing of US$7 mln private placement
* Aurinia announces closing of US$7 million private
placement
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
placement
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Nose job: smells are smart sensors' last frontier
SINGAPORE, June 23 (Reuters) - Phones or watches may be
smart enough to detect sound, light, motion, touch, direction,
acceleration and even the weather, but they can't smell.
Read more
smart enough to detect sound, light, motion, touch, direction,
acceleration and even the weather, but they can't smell.
Read more
Mateen altered looks, researched anti-psychotic drugs before attack -acquaintance
PORT ST. LUCIE, Fla., June 22 (Reuters) - On the morning
before the massacre at Orlando's Pulse gay nightclub, shooter
Omar Mateen drastically altered his appearance, shaving his head
and face, and seemed agitated and surly, said an acquaintance
who saw him that day.
Read more
before the massacre at Orlando's Pulse gay nightclub, shooter
Omar Mateen drastically altered his appearance, shaving his head
and face, and seemed agitated and surly, said an acquaintance
who saw him that day.
Read more
Zika fears sent Latin American women seeking abortion alternatives -study
CHICAGO, June 22 (Reuters) - Fearing the effects of the Zika virus on their unborn children, pregnant women in Latin America increasingly have sought out abortion pills online from a nonprofit aid agency, a new study has found.
Read more
Read more
BRIEF-Cascadian Therapeutics to sell shares of Series D convertible preferred stock
* Intends to sell shares of Series D convertible preferred
stock having an aggregate value of up to $13.8 million
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
stock having an aggregate value of up to $13.8 million
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Eiger Biopharmaceuticals CFO Welch buys 2500 shares of common stock at avg price of $19.79/shr - SEC filing
* CFO James Welch reports purchase of 2500 shares of
company's common stock at average price of $19.79 per share -
SEC filing
Source text - http://1.usa.gov/28QGX7q
Further company coverage:
Read more
company's common stock at average price of $19.79 per share -
SEC filing
Source text - http://1.usa.gov/28QGX7q
Further company coverage:
Read more
BRIEF-Grupo Ferrer buys 19.5 mln shares of Alexza Pharmaceuticals
* Grupo Ferrer Internacional, S.A. reports purchase of 19.5
mln shares of Alexza Pharmaceuticals on June 21 - SEC filing
Read more
mln shares of Alexza Pharmaceuticals on June 21 - SEC filing
Read more
UPDATE 1-U.S. House Republicans unveil healthcare alternative to Obamacare
WASHINGTON, June 22 (Reuters) - Republicans in the U.S.
House of Representatives unveiled an alternative plan to
overhaul the nation's healthcare system on Wednesday, slamming
Obamacare even as they aimed to keep some of its more popular
provisions.
Read more
House of Representatives unveiled an alternative plan to
overhaul the nation's healthcare system on Wednesday, slamming
Obamacare even as they aimed to keep some of its more popular
provisions.
Read more
BRIEF-Epizyme initiates collaboration on combination trial of tazemetostat and tecentriq for treatment of Non-Hodgkin Lymphoma
* Epizyme initiates collaboration on combination trial of
tazemetostat and tecentriq(tm)(atezolizumab) for treatment of
Non-Hodgkin Lymphoma
Read more
tazemetostat and tecentriq(tm)(atezolizumab) for treatment of
Non-Hodgkin Lymphoma
Read more
Sex trafficking victims may push rescue away, U.S. experts say
BILLINGS, Montana, June 21 (Thomson Reuters Foundation) -
R ick and Pat Freeland have cared for hundreds of troubled girls
and women at their log cabin refuge deep in the Rocky Mountains,
but there's one rule; they will only take two victims of sex
trafficking at a time.
Read more
R ick and Pat Freeland have cared for hundreds of troubled girls
and women at their log cabin refuge deep in the Rocky Mountains,
but there's one rule; they will only take two victims of sex
trafficking at a time.
Read more
BRIEF-Pharmstandard majority shareholders to buy out company shares at RUB 1,028/shr - Interfax
* Augment Investments has sent an obligatory tender offer to
the Central Bank of Russia for the purchase of Pharmstandard
shares at 1,028 roubles ($15.97) per share, Interfax
cites company statement
Further company coverage:
($1 = 64.3726 roubles)
(Gdynia Newsroom)
Read more
the Central Bank of Russia for the purchase of Pharmstandard
shares at 1,028 roubles ($15.97) per share, Interfax
cites company statement
Further company coverage:
($1 = 64.3726 roubles)
(Gdynia Newsroom)
Read more
BRIEF-Japan's Fujifilm says signed patent licensing agreement with China's Zhejiang Hisun Pharmaceutical involving drug Avigan- Nikkei
* Japan's Fujifilm has signed patent licensing agreement
with china's Zhejiang Hisun Pharmaceutical involving drug
Avigan,used to treat ebola - Nikkei
Read more
with china's Zhejiang Hisun Pharmaceutical involving drug
Avigan,used to treat ebola - Nikkei
Read more
BRIEF-Sphera Funds Management reports 7.6 pct passive stake in Vistagen Therapeutics as of May 11, 2016
* Sphera Funds Management Ltd reports 7.6 percent passive
stake in Vistagen Therapeutics Inc as of May 11, 2016 - Sec
filing
Source - http://1.usa.gov/28PKYsC
(Bengaluru Newsroom; +1 646 223 8780)
Read more
stake in Vistagen Therapeutics Inc as of May 11, 2016 - Sec
filing
Source - http://1.usa.gov/28PKYsC
(Bengaluru Newsroom; +1 646 223 8780)
Read more
BRIEF-Analogic says resolves distributor inquiry
* Reached agreements with sec, department of justice, and
danish government resolving previously disclosed fcpa
investigation
Read more
danish government resolving previously disclosed fcpa
investigation
Read more
BRIEF-Nightingale board concludes sale of assets comprising substantially all Canadian business
* Has been in discussions with potential acquirers with
intention of concluding a definitive agreement in respect of a
transaction
Read more
intention of concluding a definitive agreement in respect of a
transaction
Read more
India to revise drugs law, draft new rules for medical devices
MUMBAI, June 22 (Reuters) - India is working on revising its
drugs law to make it easier for companies to do business and to
improve the safety and efficacy of locally produced drugs, the
government said on Wednesday.
Read more
drugs law to make it easier for companies to do business and to
improve the safety and efficacy of locally produced drugs, the
government said on Wednesday.
Read more
BRIEF-A1M Pharma to use European CRO partner for preclinical toxicology studies
* Says has signed an agreement with Research Toxicology Centre, European contract research
organization, as CRO partner for the company's preclinical toxicology studies
Read more
organization, as CRO partner for the company's preclinical toxicology studies
Read more
BRIEF-Karyopharm says initiates phase 1 clinical trial with KPT-9274
* Says first-In-Human, multi-center, open-label,
dose-escalation trial is expected to enroll up to 175 patients
Read more
dose-escalation trial is expected to enroll up to 175 patients
Read more
Coloplast cuts growth forecast due to emerging markets challenges
COPENHAGEN, June 22 (Reuters) - Danish healthcare products
maker Coloplast on Wednesday adjusted its growth
forecast downwards due to a challenging macroeconomic
environment in emerging markets.
Read more
maker Coloplast on Wednesday adjusted its growth
forecast downwards due to a challenging macroeconomic
environment in emerging markets.
Read more
BRIEF-Adcare Health says New Beginnings Care becomes debtor in possession
* New beginnings care, llc became a debtor in possession in
a series of bankruptcy cases jointly administered under new
beginnings care, llc, et al., bankr. e.d. Tn chattanooga
division
Read more
a series of bankruptcy cases jointly administered under new
beginnings care, llc, et al., bankr. e.d. Tn chattanooga
division
Read more
BRIEF-Universal American says sale of traditional insurance business to close in Q3, 2016
* Sale of traditional insurance business to nassau
reinsurance group holdings, l.p. Is expected to close in q3 of
2016
Read more
reinsurance group holdings, l.p. Is expected to close in q3 of
2016
Read more
BRIEF-FIT Biotech: Tekes issues claim to partly reclaim capital loan
* Says Finnish Funding Agency for Innovation (Tekes) issues claim to partly reclaim capital
loan related to Fit Biotech HIV vaccine project in 2009-2010
Read more
loan related to Fit Biotech HIV vaccine project in 2009-2010
Read more
BRIEF-Recipharm announces global serialisation collaboration
* Says has
formed a global partnership with Marchesini, SEA Vision and
TraceLink to introduce new serialisation capabilities
Source text for Eikon:
Further company coverage:
(Stockholm Newsroom)
Read more
formed a global partnership with Marchesini, SEA Vision and
TraceLink to introduce new serialisation capabilities
Source text for Eikon:
Further company coverage:
(Stockholm Newsroom)
Read more
Tuesday, June 21, 2016
BRIEF-Beijing Beilu Pharmaceutical to pay 2015 dividend on June 28
* Says it will pay cash dividend of 0.2 yuan per 10 shares
(before tax) to shareholders of record on June 27 for 2015
Read more
(before tax) to shareholders of record on June 27 for 2015
Read more
U.S. House Speaker Ryan unveils Republican alternative to Obamacare
WASHINGTON, June 22 (Reuters) - U.S. House of
Representatives Speaker Paul Ryan unveiled a Republican
healthcare agenda on Wednesday that would repeal Obamacare but
keep some of its more popular provisions.
Read more
Representatives Speaker Paul Ryan unveiled a Republican
healthcare agenda on Wednesday that would repeal Obamacare but
keep some of its more popular provisions.
Read more
BRIEF-Harbin Gloria Pharmaceuticals updates pharma subsidiary sale to Shanxi C&Y
* Says it signed a new agreement to sell pharma subsidiary
to Shanxi C&Y, for 3.1 billion yuan
Read more
to Shanxi C&Y, for 3.1 billion yuan
Read more
BRIEF-Alteogen announces patent granted
* Says it receives a patent on May 31, for modified antibody
in which motif comprising cysteine residue is bound, modified
antibody-drug conjugate comprising the modified antibody, and
production
Read more
in which motif comprising cysteine residue is bound, modified
antibody-drug conjugate comprising the modified antibody, and
production
Read more
BRIEF-ILDONG PHARMACEUTICAL announces patent granted
* Says it receives a patent on June 22, for micro
encapsulation of spore-forming probiotics removed an autolysin
and spore-forming probiotics prepared thereby
Read more
encapsulation of spore-forming probiotics removed an autolysin
and spore-forming probiotics prepared thereby
Read more
BRIEF-Universal American announces pricing of $100 mln private offering of convertible senior notes and stock repurchase
* Announces pricing of $100 million private offering of
convertible senior notes and stock repurchase
Read more
convertible senior notes and stock repurchase
Read more
PRESS DIGEST- British Business - June 22
June 22 (Reuters) - The following are the top stories on the
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
Argentina's YPF partners with GE to build generating plant
BUENOS AIRES, June 21 (Reuters) - Argentina's state oil
company YPF said on Tuesday it was partnering with
General Electric to build a $170 million generating plant
in the northern province of Tucuman.
Read more
company YPF said on Tuesday it was partnering with
General Electric to build a $170 million generating plant
in the northern province of Tucuman.
Read more
BRIEF-Vivus receives notice from Hetero USA that it has filed with U.S. FDA ANDA for generic versions of all strengths of Stendra tablets
* Received notice from Hetero USA that it has filed with
U.S. FDA ANDA for generic versions of all strengths of Stendra
tablets
Read more
U.S. FDA ANDA for generic versions of all strengths of Stendra
tablets
Read more
BRIEF-Eli Lilly Canada says Health Canada approves Taltz for treatment of moderate-to-severe plaque psoriasis
* Eli Lilly Canada says Health Canada has granted approval
for Taltz for treatment of moderate-to-severe plaque psoriasis
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780; )
Read more
for Taltz for treatment of moderate-to-severe plaque psoriasis
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780; )
Read more
BRIEF-MiMedx Group reaches settlement with Medline Industries and Liventa Bioscience for certain claims
* MiMedx reaches settlement with Medline Industries and
Liventa Bioscience for certain claims
Read more
Liventa Bioscience for certain claims
Read more
BRIEF-Biostage CEO provides mid-year update to shareholders
* Now have capital to get through a number of milestones in
2016 including filing of IND; expect to move into human clinical
trials in 2017
Read more
2016 including filing of IND; expect to move into human clinical
trials in 2017
Read more
BRIEF-Redhill Biopharma announces positive final results with endpoints in phase 1 study with Yeliva
* Redhill Biopharma announces positive final results with
primary and secondary endpoints met in phase 1 study with
Yeliva in advanced solid tumors
Read more
primary and secondary endpoints met in phase 1 study with
Yeliva in advanced solid tumors
Read more
UPDATE 2-Impax buys generic drugs from Teva, Allergan for $586 mln
June 21 (Reuters) - Impax Laboratories Inc said it
would buy a portfolio of generic drugs from Teva Pharmaceutical
Industries Ltd and Allergan Plc for about $586
million.
Read more
would buy a portfolio of generic drugs from Teva Pharmaceutical
Industries Ltd and Allergan Plc for about $586
million.
Read more
Hedge fund Visium's Valvani found dead in apparent suicide: police
June 21 (Reuters) - Sanjay Valvani, a hedge fund manager at
Visium Asset Management LP who was arrested last week on insider
trading charges, has been found dead in an apparent suicide, the
police said on Tuesday.
Read more
Visium Asset Management LP who was arrested last week on insider
trading charges, has been found dead in an apparent suicide, the
police said on Tuesday.
Read more
BRIEF-LifeAssays Q2 sales shows same positive trend as in Q1
* Sales in Q2 have shown same positive trend as in Q1
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Euris gets second order for its new patient-oriented veterinary diagnostic systems
* Says has received second order for its new patient-oriented veterinary diagnostic systems
from the newly appointed distributor in Lithuania
Read more
from the newly appointed distributor in Lithuania
Read more
BRIEF-Perrigo Company launches non-GMO infant formulas
* Perrigo announces FDA clearance and launch of non-GMO
infant formulas for the U.S. Store brand market
Read more
infant formulas for the U.S. Store brand market
Read more
BRIEF-Progenics Pharmaceuticals signs commercial license agreement with Selexis SA
* Under agreement, progenics will have use of Selexis CHO-M
cell line and sure technology platform
Read more
cell line and sure technology platform
Read more
BRIEF-Redhill Biopharma says Yeliva met main goal in early-stage study in solid tumors
* Redhill biopharma announces positive final results with
primary and secondary endpoints met in phase 1 study with
yeliva in advanced solid tumors
Read more
primary and secondary endpoints met in phase 1 study with
yeliva in advanced solid tumors
Read more
BRIEF-Royal Philips acquires PathXL
* Philips expands its digital pathology solutions portfolio
with the acquisition of PathXL
Source text for Eikon:
Further company coverage:
Read more
with the acquisition of PathXL
Source text for Eikon:
Further company coverage:
Read more
Deals of the day- Mergers and acquisitions
June 21 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 0930 GMT on Tuesday:
Read more
acquisitions and disposals were reported by 0930 GMT on Tuesday:
Read more
BRIEF-Sernova announces non-brokered private placement
* Sernova announces non-brokered private placement
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
GE seeks to sell remaining Hyundai Capital stake - Hyundai Motor
SEOUL, June 21 (Reuters) - South Korean car maker Hyundai
Motor Co said on Tuesday General Electric
seeks to sell out of its 20 percent stake in their joint
venture, unlisted lender Hyundai Capital, to a third party.
Read more
Motor Co said on Tuesday General Electric
seeks to sell out of its 20 percent stake in their joint
venture, unlisted lender Hyundai Capital, to a third party.
Read more
BRIEF-1nkemia invests in startups to create synergy
* Says buys 10.5 percent stake for 150,000 euros ($170,000)
in Kowlco Consciumers (Abouit) and becomes reference laboratory
for Abouit
Read more
in Kowlco Consciumers (Abouit) and becomes reference laboratory
for Abouit
Read more
UPDATE 1-Philips buys Northern Irish medical imaging company
* CEO says deals shows company's new healthcare focus
(Updates after company spokesman says digital pathology sales
will be "several tens of millions" this year, rather than just
10 million, including the acquisition.)
Read more
(Updates after company spokesman says digital pathology sales
will be "several tens of millions" this year, rather than just
10 million, including the acquisition.)
Read more
BRIEF-Sichuan Swellfun appoints Ho Danny as CFO
June 21 (Reuters) - Sichuan Swellfun Co., Ltd:
* Says it appointed Ho Danny as CFO of the company
Source text in Chinese: http://me2.do/5FLMuHfc
Further company Coverage:
(Beijing Headline News)
Read more
Monday, June 20, 2016
Swiss stocks - Factors to watch on June 21
ZURICH, June 21 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Tuesday.
Read more
main factors expected to affect Swiss stocks on Tuesday.
Read more
BRIEF-Biocartis launches advanced EGFR Mutation Assay
* Launches advanced EGFR Mutation Assay detecting over 50
mutations
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
mutations
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Kunming Longjin Pharmaceutical to sell unit for 2 mln yuan
* Says it to sell its wholly owned Beijing-based
pharmaceutical technology development subsidiary to an
individual for 2 million yuan
Read more
pharmaceutical technology development subsidiary to an
individual for 2 million yuan
Read more
BRIEF-Cawachi repurchases shares at about 1 bln yen
* Says it repurchased 383,900 shares of its common stock, at
the price of 999,972,400 yen in total, from June 1 to June 20
Read more
the price of 999,972,400 yen in total, from June 1 to June 20
Read more
BRIEF-Theravance Biopharma highlights positive results from phase 3 fulfil study of closed triple announced by Glaxosmithkline, Innoviva
* Highlights positive top-line results from pivotal phase 3
fulfil study of closed triple announced by Glaxosmithkline,
Innoviva
Read more
fulfil study of closed triple announced by Glaxosmithkline,
Innoviva
Read more
BRIEF-Immune Pharmaceuticals data shows that ceplene enhances response to anti PD-1 AND ANTI-PD-l1 immune checkpoint inhibitors
* New data shows that Ceplene enhances response to anti
pd-1 and anti-pd-l1 immune checkpoint inhibitors in lymphoma and
solid tumor models
Read more
pd-1 and anti-pd-l1 immune checkpoint inhibitors in lymphoma and
solid tumor models
Read more
BRIEF-Viking Therapeutics' equity distribution agreement with Maxim Group
* Equity distribution agreement with Maxim Group Llc where
co may offer, sell from time to time, through maxim up to 3.7
million shares
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
co may offer, sell from time to time, through maxim up to 3.7
million shares
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Cellular Biomedicine Group announces resale of up to 5.1 mln shares of common stock for sale by selling stockholders
* Resale of up to 5.1 million shares of common stock for
sale by the selling stockholders - SEC filing
Source text: http://1.usa.gov/28JLGsV
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
sale by the selling stockholders - SEC filing
Source text: http://1.usa.gov/28JLGsV
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-Scynexis launches public offering of common stock and warrants
* Scynexis announces launch of public offering of common
stock and warrants
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
stock and warrants
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-HTG Molecular appoints new vice president of North American capital sales
* HTG Molecular appoints new vice president of North
American capital sales for the HTG Edgeseq platform
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
American capital sales for the HTG Edgeseq platform
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Eli Lilly sets quarterly dividend of $0.51/shr
* Sets quarterly dividend of $0.51 per share
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Seres Therapeutics says to begin SER-262 Phase 1b study in mid-2016
* Seres Therapeutics presents new data at ASM Microbe 2016,
including characterization of SER-262, the rationally-designed,
fermented microbiome therapeutic candidate for primary
clostridium difficile infection
Read more
including characterization of SER-262, the rationally-designed,
fermented microbiome therapeutic candidate for primary
clostridium difficile infection
Read more
BRIEF-Ultragenyx appoints Karah Parschauer as executive vice president, general counsel
* Ultragenyx appoints Karah Parschauer as executive vice
president, general counsel
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
president, general counsel
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Adaptimmune Therapeutics receives positive opinion
* Adaptimmune receives positive opinion for orphan drug
designation in the European Union for spear t-cell therapy
targeting NY-ESO for treatment of soft tissue sarcoma
Read more
designation in the European Union for spear t-cell therapy
targeting NY-ESO for treatment of soft tissue sarcoma
Read more
BRIEF-Collegium Pharmaceutical commercially launches Xtampza ER
* Announced commercial launch of Xtampza er (oxycodone)
extended-release (ER) capsules in united states
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
extended-release (ER) capsules in united states
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Oncternal receives fast track designation for TK216 in relapsed or refractory ewing sarcoma
* Oncternal receives fast track designation for TK216 in
relapsed or refractory ewing sarcoma
Read more
relapsed or refractory ewing sarcoma
Read more
UPDATE 1-India announces sweeping reforms to foreign direct investment rules
* Full foreign ownership allowed in defence, civil aviation
(New throughout with announcement)
Read more
(New throughout with announcement)
Read more
India now most open economy in world for FDI - Modi
NEW DELHI, June 20 (Reuters) - Indian Prime Minister
Narendra Modi hailed a sweeping liberalisation of rules on
foreign direct investment on Monday, saying they would make
Asia's third-largest economy the most open in the world.
Read more
Narendra Modi hailed a sweeping liberalisation of rules on
foreign direct investment on Monday, saying they would make
Asia's third-largest economy the most open in the world.
Read more
BRIEF-Daiichi Sankyo plans 28 mln shares repurchase
* Says it plans to buy 28 million shares (4.1 percent
outstanding) back, for up to 500 million yen, from June 21 to
Oct. 28
Read more
outstanding) back, for up to 500 million yen, from June 21 to
Oct. 28
Read more
CORRECTED-Circassia's cat allergy treatment fails late-stage trial
June 20 (Reuters) - Drug developer Circassia Pharmaceuticals
Plc said its cat allergy treatment failed to meet its
main goal in a late-stage study, due to a marked placebo effect.
Read more
Plc said its cat allergy treatment failed to meet its
main goal in a late-stage study, due to a marked placebo effect.
Read more
BRIEF-Milestone Scientific ups votes in Milestone Medical to 98.1 pct
* Said on Friday that as a result of a share exchange agreement, Milestone Scientific Inc
has acquired 2,413,978 shares of Milestone Medical Inc
Read more
has acquired 2,413,978 shares of Milestone Medical Inc
Read more
BRIEF-SEOUL PHARMA says conversion of convertible bonds worth 1.3 bln won
* Says 1.3 billion won worth of its second convertible bonds
have been converted into 92,425 shares of the company at 14,100
won per share
Read more
have been converted into 92,425 shares of the company at 14,100
won per share
Read more
CORRECTED-German stocks - Factors to watch on June 20
FRANKFURT, June 20 (Reuters) - The DAX top-30 index
looked set to open 2.2 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0600 GMT.
Read more
looked set to open 2.2 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0600 GMT.
Read more
Sunday, June 19, 2016
Roche announces availability of LightMix modular Zika Virus Assay
ZURICH, June 20 (Reuters) - Swiss drugmaker Roche
said on Monday its LightMix Modular Zika Virus Assay (CE) is
available in markets accepting the CE mark for patients with
signs and symptoms of the Zika infection where the virus is
known to be present.
Read more
said on Monday its LightMix Modular Zika Virus Assay (CE) is
available in markets accepting the CE mark for patients with
signs and symptoms of the Zika infection where the virus is
known to be present.
Read more
BRIEF-Paion reports positive remimazolam headline data in phase III study in procedural sedation for colonoscopy
* Said on Sunday remimazolam met its primary efficacy
endpoint in the first study of its pivotal U.S. Phase III
program in patients undergoing procedural sedation
Read more
endpoint in the first study of its pivotal U.S. Phase III
program in patients undergoing procedural sedation
Read more
Swiss stocks - Factors to watch on June 20
ZURICH, June 20 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
Read more
factors that may affect Swiss stocks on Monday:
Read more
BRIEF-Jinyu Bio-Technology to pay 2015 dividend on June 24
* Says it will use undistributed profits to pay a cash
dividend of 4 yuan (pre-tax) per 10 shares to shareholders of
record on June 23 for 2015
Read more
dividend of 4 yuan (pre-tax) per 10 shares to shareholders of
record on June 23 for 2015
Read more
PRESS DIGEST- Financial Times - June 20
June 20 (Reuters) - The following are the top stories in the
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Antitrust regulators worry about proposed Cigna-Anthem merger -WSJ
June 19 (Reuters) - U.S. antitrust regulators are concerned
about health insurer Anthem Inc's proposed acquisition
of Cigna Corp and not sure the companies can offer enough
concessions to maintain competition in the industry, the Wall
Street Journal reported on Sunday.
Read more
about health insurer Anthem Inc's proposed acquisition
of Cigna Corp and not sure the companies can offer enough
concessions to maintain competition in the industry, the Wall
Street Journal reported on Sunday.
Read more
Immigration, abortion, race rulings due at U.S. Supreme Court
WASHINGTON, June 19 (Reuters) - The U.S. Supreme Court is
heading into its home stretch, with major rulings due by the end
of the month on President Barack Obama's unilateral immigration
plan, racial preferences in university admissions and a
restrictive Texas abortion law.
Read more
heading into its home stretch, with major rulings due by the end
of the month on President Barack Obama's unilateral immigration
plan, racial preferences in university admissions and a
restrictive Texas abortion law.
Read more
BRIEF-Joben Bio-Medical gets patent in China
* Says it got patent for a kind of nerve protective
composition and its application in China
Read more
composition and its application in China
Read more
BRIEF-Hunan Jingfeng Pharmaceutical to pay 2015 dividend on June 23
* Says it will pay a cash dividend of 1 yuan (before tax)
per 10 shares and use additional paid-in capital to distribute 1
new shares for every 10 shares, to shareholders of record on
June 22 for 2015
Read more
per 10 shares and use additional paid-in capital to distribute 1
new shares for every 10 shares, to shareholders of record on
June 22 for 2015
Read more
Hologic wins emergency U.S. authorization for Zika test
June 17 (Reuters) - Hologic Inc won emergency U.S.
authorization to sell its Zika test, expanding the number of
public and private labs that can test for the virus as health
officials brace for a rise this summer in the number of
infections.
Read more
authorization to sell its Zika test, expanding the number of
public and private labs that can test for the virus as health
officials brace for a rise this summer in the number of
infections.
Read more
Friday, June 17, 2016
BRIEF-Cellectar Biosciences files for resale of 300,006 shares
* Files for resale of 300,006 shares of common stock offered
by selling stockholders - SEC filing
Source text - http://1.usa.gov/1Xus1yR
Further company coverage:
Read more
by selling stockholders - SEC filing
Source text - http://1.usa.gov/1Xus1yR
Further company coverage:
Read more
BRIEF-Neogenomics files for stock shelf of up to $200 mln
* Files for stock shelf of up to $200 million - SEC filing
Source text -http://1.usa.gov/24WtPQB
Further company coverage:
Read more
Source text -http://1.usa.gov/24WtPQB
Further company coverage:
Read more
Kosovo minister quits following health bribery probe
PRISTINA, June 17 (Reuters) - Kosovo's environment minister
resigned on Friday after a prosecutor filed charges against him
for allegedly channelling illegal payments to private hospitals
while he was health minister in the previous government.
Read more
resigned on Friday after a prosecutor filed charges against him
for allegedly channelling illegal payments to private hospitals
while he was health minister in the previous government.
Read more
As rate hike worries fades, M&A bond issuers hold off
NEW YORK, June 17 (IFR) - After weeks of hectic issuance,
the US primary high-grade market is set to slow as companies
slam the brakes on jumbo bond sales to finance mergers and
acquisitions until the autumn.
Read more
the US primary high-grade market is set to slow as companies
slam the brakes on jumbo bond sales to finance mergers and
acquisitions until the autumn.
Read more
BRIEF-Crossject delays filing of marketing authorization for Zénéo Adrenaline
* Due to a delay in bioequivalence study led by its customer, filing of marketing
authorization for Zénéo Adrenaline should be delayed several months as well
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
authorization for Zénéo Adrenaline should be delayed several months as well
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Abivax says primary endpoint of ABX203 Phase IIb/III trial unlikely to be reached
* Analysis of ongoing ABX203 Phase IIb/III trial in chronic Hepatitis B virus infection
shows good safety, but primary endpoint of study is unlikely to be reached
Read more
shows good safety, but primary endpoint of study is unlikely to be reached
Read more
South African "virgin bursaries" scheme ruled unconstitutional
JOHANNESBURG, June 17 (Reuters) - A controversial scheme
offering university scholarships to young South African women
who remain virgins is unconstitutional, the Commission for
Gender Equality ruled on Friday.
Read more
offering university scholarships to young South African women
who remain virgins is unconstitutional, the Commission for
Gender Equality ruled on Friday.
Read more
RPT-South African "virgin bursaries" scheme ruled unconstitutional
JOHANNESBURG, June 17 (Reuters) - A controversial scheme
offering university scholarships to young South African women
who remain virgins is unconstitutional, the Commission for
Gender Equality ruled on Friday.
Read more
offering university scholarships to young South African women
who remain virgins is unconstitutional, the Commission for
Gender Equality ruled on Friday.
Read more
BRIEF-BrainCool: Receives proceeds of about SEK 14.5 mln through share issue
* Company receives proceeds of 14.5 million Swedish crowns ($1.74 million) before issue
costs of 800,000 crowns
Read more
costs of 800,000 crowns
Read more
BRIEF-Oxigene announces name change to Mateon Therapeutics
* Announced that it has changed its name to Mateon
Therapeutics, Inc., effective immediately
Read more
Therapeutics, Inc., effective immediately
Read more
BRIEF-Ginwa Enterprise adjusts private placement, to raise up to 963.3 mln yuan
* Says it adjusts private placement plan, to raise up to
963.3 million yuan ($146.19 million)
Read more
963.3 million yuan ($146.19 million)
Read more
UPDATE 1-WHO backs plan to cut yellow vaccine dose to eke out supplies
* One-fifth vaccine dose expected to protect for at least 1
year
(Adds details on vaccine supply, yellow fever outbreaks)
Read more
year
(Adds details on vaccine supply, yellow fever outbreaks)
Read more
WHO says $122 million needed for global response to Zika virus
LONDON, June 17 (Reuters) - Almost $122 million is needed to
prevent and manage the medical complications of the Zika virus
spreading throughout the Americas and causing birth defects in
babies, the World Health Organization said on Friday.
Read more
prevent and manage the medical complications of the Zika virus
spreading throughout the Americas and causing birth defects in
babies, the World Health Organization said on Friday.
Read more
Lifting U.S. curbs on gay blood donors seen years away -experts
NEW YORK/WASHINGTON, June 17 (Reuters) - U.S. health
regulators are under increasing pressure to remove restrictions
keeping most gay and bisexual men from donating blood, but
experts say any change would require years of research to
guarantee the safety of the blood supply.
Read more
regulators are under increasing pressure to remove restrictions
keeping most gay and bisexual men from donating blood, but
experts say any change would require years of research to
guarantee the safety of the blood supply.
Read more
BRIEF-Guangdong Biolight Meditech to buy 20 pct stake in minimally invasive medical device company at 20 mln yuan
* Says it will buy 20 percent stake in a Changzhou-based
minimally invasive medical device company at 20 million yuan
Read more
minimally invasive medical device company at 20 million yuan
Read more
UPDATE 2-Singapore May exports post surprise jump on gold, drugs shipments
* NODX to China -10.1 pct y/y, to Europe -14.0 pct y/y
(Adds comments and details on gold exports,)
Read more
(Adds comments and details on gold exports,)
Read more
BRIEF-Olympus announces application of International Financial Reporting Standards
* Says it plans to apply International Financial Reporting
Standards (IFRS) as the new accounting method, to replace the
current Japan-Generally Accepted Accounting Principles
Read more
Standards (IFRS) as the new accounting method, to replace the
current Japan-Generally Accepted Accounting Principles
Read more
BRIEF-Vivoline Medical applies for delisting
* Applies for delisting from First North
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Thursday, June 16, 2016
British companies prepare for long night to possible Brexit
LONDON, June 17 (Reuters) - British companies are preparing
for the possibility that the country will vote to leave the
European Union with extra funds, pre-written statements and
plans for late-night vigils by teams of consultants.
Read more
for the possibility that the country will vote to leave the
European Union with extra funds, pre-written statements and
plans for late-night vigils by teams of consultants.
Read more
BRIEF-Swissmed Centrum Zdrowia Q4 2015/2016 net loss shrinks to 642,000 zlotys
* Q4 2015/2016 revenue 9.3 million zlotys ($2.4
million)versus 9.9 million zlotys a year ago
Read more
million)versus 9.9 million zlotys a year ago
Read more
BRIEF-Innocoll Holdings prices 5.7 mln shares offering at $7.00 per share
* Says priced an underwritten public offering of 5.7 million
shares at $7.00 per share for aggregate gross proceeds of $40.1
million
Read more
shares at $7.00 per share for aggregate gross proceeds of $40.1
million
Read more
BRIEF-Lansdowne Partners believes Grupo Ferrer's unit tender offer to buy alexza pharma's shares not fair
* Believe tender offer commenced by subsidiary of grupo
ferrer to buy alexza pharma's shares at $0.90per share neither
fair nor in best interests of stockholders
Read more
ferrer to buy alexza pharma's shares at $0.90per share neither
fair nor in best interests of stockholders
Read more
BRIEF-Spineguard receives US FDA clearance to market PediGuard
* Receives U.S. FDA clearance to market PediGuard Threaded
DSG device
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
DSG device
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Oncosec Medical presents preliminary findings from head and neck phase II clinical trial
* Oncosec presents preliminary findings from head and neck
phase ii clinical trial at eurogin 2016 conference
Read more
phase ii clinical trial at eurogin 2016 conference
Read more
Roche skin cancer drugs "too expensive", says UK cost agency
LONDON, June 16 (Reuters) - Roche's two-drug
combination of Cotellic and Zelboraf for melanoma was rejected
by Britain's healthcare cost agency NICE as "too expensive" on
Thursday, in contrast to the green light given in April to a
rival cocktail from Novartis.
Read more
combination of Cotellic and Zelboraf for melanoma was rejected
by Britain's healthcare cost agency NICE as "too expensive" on
Thursday, in contrast to the green light given in April to a
rival cocktail from Novartis.
Read more
U.S. top court sends healthcare fraud claim case back to lower court
WASHINGTON, June 16 (Reuters) - The U.S. Supreme Court on
Thursday threw out an appeals court ruling that went against
hospital operator Universal Health Services Inc over
whether it has to face a lawsuit accusing it of defrauding the
government in a case arising from a Massachusetts woman's death
at a mental health facility.
Read more
Thursday threw out an appeals court ruling that went against
hospital operator Universal Health Services Inc over
whether it has to face a lawsuit accusing it of defrauding the
government in a case arising from a Massachusetts woman's death
at a mental health facility.
Read more
BRIEF-Pharmacolog gets financing from Vinnova for integrating DrugLog with clinical drug system
* Vinnova has granted the Karolinska University Hospital and Pharmacolog AB funds for a
joint development project for safer and more effective medication
Read more
joint development project for safer and more effective medication
Read more
Merck's Keytruda prolongs life in big lung-cancer study
June 16 (Reuters) - Advanced lung cancer patients who took
Merck & Co's Keytruda immuno-oncology medicine in a
large trial and were previously untreated went longer without
their disease worsening and showed a survival advantage over
those given standard chemotherapy, the drugmaker said on
Thursday.
Read more
Merck & Co's Keytruda immuno-oncology medicine in a
large trial and were previously untreated went longer without
their disease worsening and showed a survival advantage over
those given standard chemotherapy, the drugmaker said on
Thursday.
Read more
BRIEF-Beleave appoints Dana Gidlow head of veteran affairs and community outreach
* Beleave appoints retired lieutenant colonel Dana Gidlow as
head of veteran affairs and community outreach
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
head of veteran affairs and community outreach
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Spectral Medical says FDA accepts pre-clinical PMA module for Toraymyxin(TM)
* Spectral Medical says FDA accepts pre-clinical PMA module
for Toraymyxin(tm)
Source text for Eikon:
Further company coverage:
Read more
for Toraymyxin(tm)
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Karyopharm completes enrollment in ongoing storm study; results expected mid-2016
* To report top-line data from phase 1b clinical trial of
selinexor in combination with some agents over next 18 months
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
selinexor in combination with some agents over next 18 months
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Amsurg says on termination of merger, co may be required to pay $180 mln to Envision
* On termination of merger agreement, under some
circumstances, co may be required to pay a termination fee of
$180 million to envision - sec filing
Read more
circumstances, co may be required to pay a termination fee of
$180 million to envision - sec filing
Read more
BRIEF-Sanochemia Pharmazeutika announces cooperation with b.e.imaging and SPL Medical B.V.
* Announces cooperation with b.e.imaging and SPL Medical
B.V.
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
B.V.
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-TaiwanJ Pharmaceuticals to issue 20 mln new shares
* Says it will issue 20 million new shares of its common
stock with par value of T$10 per share and issue price at T$35
per share
Read more
stock with par value of T$10 per share and issue price at T$35
per share
Read more
BRIEF-Shanghai Runda Medical to acquire stake in Canada's Response Biomedical
* Says it plans to acquire about 43.1 percent stake in
Response Biomedical Corp for up to $6 million
Read more
Response Biomedical Corp for up to $6 million
Read more
Spain's ACS close to selling Urbaser waste group -media
MADRID, June 16 (Reuters) - Spanish builder and service
provider ACS is close to finalising the sale of its
waste management business Urbaser to Chinese groups for more
than 2 billion euros ($2.3 bln), two newspapers reported on
Thursday.
Read more
provider ACS is close to finalising the sale of its
waste management business Urbaser to Chinese groups for more
than 2 billion euros ($2.3 bln), two newspapers reported on
Thursday.
Read more
UPDATE 2-UK Stocks-Factors to watch on June 16
June 16 (Reuters) - Britain's FTSE 100 index is seen opening down 41
points, or 0.7 percent lower, on Thursday, according to financial bookmakers,
with futures down over 1 percent ahead of the cash market open. For more
on the factors affecting European stocks, please click on
Read more
points, or 0.7 percent lower, on Thursday, according to financial bookmakers,
with futures down over 1 percent ahead of the cash market open. For more
on the factors affecting European stocks, please click on
Read more
BRIEF-Caregen signs contract worth 874.4 mln won
* Says it signed contract with PALMED Health Products Trade
& Ltd. Co., to supply Prostrolane for osteoarthritis treatment
uses
Read more
& Ltd. Co., to supply Prostrolane for osteoarthritis treatment
uses
Read more
Wednesday, June 15, 2016
Swiss stocks - Factors to watch on June 16
ZURICH, June 16 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.9 percent lower at 7,612 points on Thursday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.9 percent lower at 7,612 points on Thursday,
according to premarket indications by bank Julius Baer
.
Read more
BRIEF-Fagron launches 88.2 million euro capital increase
* Capital increase with preferential subscription rights of
maximum 88,265,360.40 euros ($99.54 million) through issuance
of maximum 17,105,690 new shares at an issue price of 5.16 euros
per share
Read more
maximum 88,265,360.40 euros ($99.54 million) through issuance
of maximum 17,105,690 new shares at an issue price of 5.16 euros
per share
Read more
UK Stocks-Factors to watch on June 16
June 16 (Reuters) - Britain's FTSE 100 index is seen opening down 41
points, or 0.7 percent lower, on Thursday, according to financial bookmakers.
For more on the factors affecting European stocks, please click on
* The UK blue chip index closed 0.7 percent higher at 5,966.80 points on
Wednesday, as a rally in metals prices following a weaker dollar boosted basic
resources stocks, although housebuilders came under pressure ahead of a vote on
the country's European Union membership.
Read more
points, or 0.7 percent lower, on Thursday, according to financial bookmakers.
For more on the factors affecting European stocks, please click on
* The UK blue chip index closed 0.7 percent higher at 5,966.80 points on
Wednesday, as a rally in metals prices following a weaker dollar boosted basic
resources stocks, although housebuilders came under pressure ahead of a vote on
the country's European Union membership.
Read more
Fitch Rates Hua Han's USD Senior Notes Final 'BB-'
(The following statement was released by the rating agency)
HONG KONG/SHANGHAI, June 15 (Fitch) Fitch Ratings has assigned
Hua Han Health
Industry Holdings Limited's (Hua Han, BB-/Stable) USD150m 7.00%
senior notes due
16 June 2019 a final rating of 'BB-'.
The notes are rated at the same level as Hua Han' senior
unsecured rating
because they are regarded as direct and senior unsecured
obligations of the
company. The assignment of the final rating follows the receipt
of documents
conforming
Read more
HONG KONG/SHANGHAI, June 15 (Fitch) Fitch Ratings has assigned
Hua Han Health
Industry Holdings Limited's (Hua Han, BB-/Stable) USD150m 7.00%
senior notes due
16 June 2019 a final rating of 'BB-'.
The notes are rated at the same level as Hua Han' senior
unsecured rating
because they are regarded as direct and senior unsecured
obligations of the
company. The assignment of the final rating follows the receipt
of documents
conforming
Read more
BRIEF-Apeloa Pharmaceutical to pay 2015 dividend on June 21
* Says it will pay a cash dividend of 0.55 yuan (pre-tax)
for every 10 shares to shareholders of record on June 20 for
2015
Read more
for every 10 shares to shareholders of record on June 20 for
2015
Read more
PRESS DIGEST- British Business - June 16
June 16 (Reuters) - The following are the top stories on the
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
BRIEF-LabGenomics announces patent granted
* Says it receives a patent license on June 15, for
providing dielectric analysis related service and method thereof
Read more
providing dielectric analysis related service and method thereof
Read more
BRIEF-Aveo Pharmaceuticals says sale of 37.1 mln shares by stockholders
* Announces sale of 37.1 million shares of common stock by
selling stockholders - sec filing
Source text - (http://1.usa.gov/1VZX0ly)
Further company coverage:
Read more
selling stockholders - sec filing
Source text - (http://1.usa.gov/1VZX0ly)
Further company coverage:
Read more
BRIEF-Envision Healthcare and AmSurg to merge
* Combined organization will have a pro forma market
capitalization of approximately $10 billion and enterprise value
of approximately $15 billion
Read more
capitalization of approximately $10 billion and enterprise value
of approximately $15 billion
Read more
BRIEF-Corium International says initiated reduction in workforce
* On June 14, 2016, co approved and initiated a reduction in
its workforce of employees and contractors - SEC filing
Read more
its workforce of employees and contractors - SEC filing
Read more
BRIEF-Odontoprev announces own capital interest payment
* Announced on Tuesday that its board approved, ad
referendum of the general meeting of shareholders, own capital
interest payment totalling gross 11.4 million Brazilian reais
($3.3 million), corresponding to 0.0216 real per share
Read more
referendum of the general meeting of shareholders, own capital
interest payment totalling gross 11.4 million Brazilian reais
($3.3 million), corresponding to 0.0216 real per share
Read more
Subscribe to:
Posts (Atom)